Clonidine

Identification

Summary

Clonidine is an alpha-2 adrenergic agonist used to treat hypertension and severe cancer pain, among other conditions, and to treat withdrawal symptoms from various substances. It is also used to aid in the diagnosis of pheochromocytoma and to prevent migraines.

Brand Names
Catapres, Catapres-TTS, Catapres-tts-1, Duraclon, Kapvay, Nexiclon XR
Generic Name
Clonidine
DrugBank Accession Number
DB00575
Background

Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors.2 This activity is useful for the treatment of hypertension, severe pain, and ADHD.8,9,10,11

Clonidine was granted FDA approval on 3 September 1974.8

Type
Small Molecule
Groups
Approved
Structure
Weight
Average: 230.094
Monoisotopic: 229.017352717
Chemical Formula
C9H9Cl2N3
Synonyms
  • 2-((2,6-Dichlorophenyl)imino)imidazolidine
  • 2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
  • Chlofazoline
  • Clonidin
  • Clonidina
  • Clonidine
  • Clonidinum
External IDs
  • M-5041T
  • SKF 34427
  • ST 155
  • ST 155-BS

Pharmacology

Indication

Clonidine tablets and transdermal systems are indicated for the treatment of hypertension alone or in combination with other medications.8,9 A clonidine injection is indicated for use with opiates in the treatment of severe cancer pain where opiates alone are insufficient.10 An extended release tablet of clonidine is indicated for the treatment of ADHD either alone or in combination with other medications.11

Clonidine is also used for the diagnosis of pheochromocytoma,3 treatment of nicotine dependance,4 and opiate withdrawal.5

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Management ofAdhd••••••••••••••• ••••••••••• •••••••• •••••••• •••••• •••••••• •••••••• ••••••• •••••••• •••••••
Diagnostic agentGrowth hormone deficiency••• •••••
Management ofHot flashes••• •••••
Management ofHypertension••••••••••••••••••• •••••
Symptomatic treatment ofOpioid withdrawal••• •••••
Management ofOppositional defiant disorder••• •••••
Diagnostic agentPheochromocytoma••• •••••
Management ofPostherpetic neuralgia••• •••••
Treatment ofSialorrhea caused by clozapine••• •••••
Management ofTourette syndrome••• •••••
Management ofDiabetic diarrhea••• •••••
Symptomatic treatment ofMethadone withdrawal••• •••••
Management ofSevere cancer pain••••••••••••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Clonidine functions through agonism of alpha-2 adrenoceptors which have effects such as lowering blood pressure, sedation, and hyperpolarization of nerves.2 It has a long duration of action as it is given twice daily and the therapeutic window is between 0.1mg and 2.4mg daily.8,9,10,11

Mechanism of action

Clonidine is primarily an alpha-2 adrenoceptor agonist which causes central hypotensive and anti-arrhythmogenic effects.2 The alpha-2 adrenoceptor is coupled to the G-proteins Go and Gi.2 Gi inhibits adenylyl cyclase and activates opening of a potassium channel that causes hyperpolarization.2 Clonidine binding to the alpha-2 adrenoceptor causes structural changes in the alpha subunit of the G-protein, reducing its affinity for GDP.2 Magnesium catalyzes the replacement of GDP with GTP.2 The alpha subunit dissociates from the other subunits and associates with an effector.2

The stimulation of alpha-2 adrenoceptors in the locus coeruleus may be responsible for the hypnotic effects of clonidine as this region of the brain helps regulate wakefulness.2 Clonidine can also decrease transmission of pain signals at the spine.2 Finally clonidine can affect regulators of blood pressure in the ventromedial and rostral-ventrolateral areas of the medulla.2

TargetActionsOrganism
AAlpha-2B adrenergic receptor
agonist
Humans
AAlpha-2C adrenergic receptor
agonist
Humans
AAlpha-2A adrenergic receptor
agonist
Humans
UAlpha-1A adrenergic receptor
agonist
Humans
UAlpha-1B adrenergic receptor
agonist
Humans
UAlpha-1D adrenergic receptor
agonist
Humans
Absorption

Clonidine reaches maximum concentration in 60-90 minutes after oral administration.2,6 Race and fasting status do not influence pharmacokinetics of clonidine.8

A 100µg oral clonidine tablet reaches a Cmax of 400.72pg/mL with an AUC of 5606.78h*pg/mL and a bioavailability of 55-87%.6

Volume of distribution

The volume of distribution of clonidine has been reported as 1.7-2.5L/kg2, 2.9L/kg9, or 2.1±0.4L/kg10 depending on the source.

Protein binding

Clonidine is 20-40% bound to plasma proteins, especially albumin.2,10

Metabolism

The metabolism of clonidine is poorly understood.7 The main reaction in clonidine metabolism is the 4-hydroxylation of clonidine by CYP2D6, CYP1A2, CYP3A4, CYP1A1, and CYP3A5.7

Clonidine is <50% metabolized in the liver to inactive metabolites.2,8,9,10,11

Hover over products below to view reaction partners

Route of elimination

Approximately 50% of a clonidine dose is excreted in the urine as the unchanged drug and 20% is eliminated in the feces.2,8

Half-life

The elimination half life after epidural administration is 30 minutes but otherwise can range from 6-23h.2

Clearance

The clearance of clonidine is 1.9-4.3mL/min/kg.2

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Oral LD50 is 126 mg/kg in rats.12 The TDLO is 70µg/kg in children, 126µg/kg in women, and 69µg/kg in men.12

Symptoms of overdose include hypertension followed by hypotension, bradycardia, respiratory depression, hypothermia, drowsiness, decreased reflexes, weakness, irritability, and miosis.8,9,10,11 Severe overdoses can cause reversible cardiac conduction defects or dysrhythmias, apnea, coma, and seizures.8,9,10,11 Induction of vomiting is not recommended due to CNS depression but gastric lavage or activated charcoal may be useful in recent ingestion.8,9,10,11 Dialysis is also unlikely to be beneficial.8,9,10,11 Overdose can be treated with supportive measures such as atropine sulfate for bradycardia, intravenous fluids or vasopressors for hypotension, vasodilators for hypertension, naloxone for respiratory depression, and blood pressure monitoring.8,9,10,11

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
1,2-BenzodiazepineThe risk or severity of sedation can be increased when Clonidine is combined with 1,2-Benzodiazepine.
AbaloparatideThe risk or severity of adverse effects can be increased when Clonidine is combined with Abaloparatide.
AbametapirThe serum concentration of Clonidine can be increased when it is combined with Abametapir.
AbataceptThe metabolism of Clonidine can be increased when combined with Abatacept.
AbirateroneThe metabolism of Clonidine can be decreased when combined with Abiraterone.
AcalabrutinibThe metabolism of Clonidine can be decreased when combined with Acalabrutinib.
AcebutololThe risk or severity of hypotension can be increased when Clonidine is combined with Acebutolol.
AceclofenacThe therapeutic efficacy of Clonidine can be decreased when used in combination with Aceclofenac.
AcemetacinThe therapeutic efficacy of Clonidine can be decreased when used in combination with Acemetacin.
AcenocoumarolThe metabolism of Acenocoumarol can be decreased when combined with Clonidine.
AcetaminophenThe metabolism of Clonidine can be increased when combined with Acetaminophen.
AcetazolamideThe risk or severity of sedation can be increased when Clonidine is combined with Acetazolamide.
AcetophenazineThe risk or severity of sedation can be increased when Clonidine is combined with Acetophenazine.
AcetyldigitoxinClonidine may increase the atrioventricular blocking (AV block) activities of Acetyldigitoxin.
Acetylsalicylic acidAcetylsalicylic acid may decrease the antihypertensive activities of Clonidine.
AclidiniumThe risk or severity of Tachycardia can be increased when Clonidine is combined with Aclidinium.
AcyclovirThe metabolism of Acyclovir can be decreased when combined with Clonidine.
AdagrasibThe serum concentration of Clonidine can be increased when it is combined with Adagrasib.
AdalimumabThe metabolism of Clonidine can be increased when combined with Adalimumab.
AdenosineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Adenosine.
AgomelatineThe risk or severity of sedation can be increased when Clonidine is combined with Agomelatine.
AlbendazoleThe metabolism of Clonidine can be increased when combined with Albendazole.
AlbuterolSalbutamol may decrease the antihypertensive activities of Clonidine.
AlclofenacThe therapeutic efficacy of Clonidine can be decreased when used in combination with Alclofenac.
AldesleukinThe serum concentration of Clonidine can be increased when it is combined with Aldesleukin.
AlfentanilThe risk or severity of sedation can be increased when Clonidine is combined with Alfentanil.
AlfuzosinAlfuzosin may increase the hypotensive activities of Clonidine.
AlimemazineThe risk or severity of sedation can be increased when Clonidine is combined with Alimemazine.
AliskirenThe risk or severity of hypotension can be increased when Clonidine is combined with Aliskiren.
AlmotriptanThe risk or severity of sedation can be increased when Clonidine is combined with Almotriptan.
AlogliptinThe metabolism of Clonidine can be decreased when combined with Alogliptin.
AlosetronThe risk or severity of sedation can be increased when Clonidine is combined with Alosetron.
AlpelisibThe metabolism of Clonidine can be increased when combined with Alpelisib.
AlprazolamThe risk or severity of sedation can be increased when Clonidine is combined with Alprazolam.
AlverineThe risk or severity of sedation can be increased when Clonidine is combined with Alverine.
AmbrisentanThe risk or severity of hypotension can be increased when Clonidine is combined with Ambrisentan.
AmifostineClonidine may increase the hypotensive activities of Amifostine.
AmilorideThe risk or severity of adverse effects can be increased when Clonidine is combined with Amiloride.
AminoglutethimideThe metabolism of Clonidine can be increased when combined with Aminoglutethimide.
AminophenazoneThe metabolism of Clonidine can be decreased when combined with Aminophenazone.
AminophyllineThe metabolism of Aminophylline can be decreased when combined with Clonidine.
AmiodaroneClonidine may increase the atrioventricular blocking (AV block) activities of Amiodarone.
AmisulprideThe risk or severity of sedation can be increased when Clonidine is combined with Amisulpride.
AmitriptylineThe risk or severity of sedation can be increased when Clonidine is combined with Amitriptyline.
AmitriptylinoxideThe risk or severity of sedation can be increased when Clonidine is combined with Amitriptylinoxide.
AmlodipineThe risk or severity of hypotension can be increased when Clonidine is combined with Amlodipine.
AmobarbitalThe risk or severity of sedation can be increased when Clonidine is combined with Amobarbital.
AmoxapineThe risk or severity of sedation can be increased when Clonidine is combined with Amoxapine.
AmphetamineThe metabolism of Clonidine can be decreased when combined with Amphetamine.
Amphotericin BThe risk or severity of adverse effects can be increased when Clonidine is combined with Amphotericin B.
AmprenavirThe metabolism of Clonidine can be decreased when combined with Amprenavir.
Amyl NitriteThe risk or severity of adverse effects can be increased when Clonidine is combined with Amyl Nitrite.
AnagrelideThe metabolism of Clonidine can be decreased when combined with Anagrelide.
AnakinraThe metabolism of Clonidine can be increased when combined with Anakinra.
AnileridineThe therapeutic efficacy of Anileridine can be increased when used in combination with Clonidine.
Anisotropine methylbromideThe risk or severity of Tachycardia can be increased when Anisotropine methylbromide is combined with Clonidine.
AntipyrineThe metabolism of Clonidine can be decreased when combined with Antipyrine.
AntrafenineThe therapeutic efficacy of Clonidine can be decreased when used in combination with Antrafenine.
ApalutamideThe serum concentration of Clonidine can be decreased when it is combined with Apalutamide.
ApixabanThe metabolism of Clonidine can be decreased when combined with Apixaban.
ApomorphineThe risk or severity of sedation can be increased when Clonidine is combined with Apomorphine.
ApremilastThe metabolism of Clonidine can be increased when combined with Apremilast.
AprepitantThe metabolism of Clonidine can be decreased when combined with Aprepitant.
ApronalideThe risk or severity of sedation can be increased when Clonidine is combined with Apronalide.
ArbutamineArbutamine may decrease the antihypertensive activities of Clonidine.
ArformoterolThe metabolism of Clonidine can be decreased when combined with Arformoterol.
AripiprazoleThe risk or severity of sedation can be increased when Clonidine is combined with Aripiprazole.
Aripiprazole lauroxilThe risk or severity of sedation can be increased when Clonidine is combined with Aripiprazole lauroxil.
ArmodafinilThe metabolism of Clonidine can be increased when combined with Armodafinil.
Arsenic trioxideThe risk or severity of adverse effects can be increased when Clonidine is combined with Arsenic trioxide.
ArtemetherThe metabolism of Clonidine can be decreased when combined with Artemether.
ArtenimolThe metabolism of Clonidine can be decreased when combined with Artenimol.
ArticaineThe risk or severity of sedation can be increased when Clonidine is combined with Articaine.
AsciminibThe serum concentration of Clonidine can be increased when it is combined with Asciminib.
AsenapineThe risk or severity of sedation can be increased when Clonidine is combined with Asenapine.
AstemizoleThe serum concentration of Clonidine can be increased when it is combined with Astemizole.
AsunaprevirThe metabolism of Clonidine can be decreased when combined with Asunaprevir.
AtazanavirThe metabolism of Clonidine can be decreased when combined with Atazanavir.
AtenololThe risk or severity of hypotension can be increased when Clonidine is combined with Atenolol.
AtomoxetineThe metabolism of Clonidine can be decreased when combined with Atomoxetine.
AtorvastatinThe metabolism of Clonidine can be decreased when combined with Atorvastatin.
AtracuriumThe risk or severity of sedation can be increased when Clonidine is combined with Atracurium.
Atracurium besylateThe risk or severity of sedation can be increased when Clonidine is combined with Atracurium besylate.
AtropineAtropine may decrease the antihypertensive activities of Clonidine.
AvacopanThe serum concentration of Clonidine can be increased when it is combined with Avacopan.
AvanafilThe serum concentration of Avanafil can be increased when it is combined with Clonidine.
AxitinibThe metabolism of Axitinib can be decreased when combined with Clonidine.
AzathioprineThe metabolism of Azathioprine can be decreased when combined with Clonidine.
AzelastineClonidine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azilsartan medoxomilThe risk or severity of hypotension can be increased when Clonidine is combined with Azilsartan medoxomil.
AzithromycinThe metabolism of Clonidine can be decreased when combined with Azithromycin.
BaclofenThe risk or severity of sedation can be increased when Clonidine is combined with Baclofen.
BalsalazideThe therapeutic efficacy of Clonidine can be decreased when used in combination with Balsalazide.
Beclomethasone dipropionateThe metabolism of Clonidine can be increased when combined with Beclomethasone dipropionate.
BelinostatThe metabolism of Clonidine can be increased when combined with Belinostat.
BelzutifanThe serum concentration of Clonidine can be decreased when it is combined with Belzutifan.
BenazeprilThe risk or severity of hypotension can be increased when Clonidine is combined with Benazepril.
BendamustineThe metabolism of Bendamustine can be decreased when combined with Clonidine.
BendroflumethiazideThe risk or severity of hypotension can be increased when Clonidine is combined with Bendroflumethiazide.
BenorilateThe therapeutic efficacy of Clonidine can be decreased when used in combination with Benorilate.
BenoxaprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Benoxaprofen.
BenperidolThe risk or severity of sedation can be increased when Clonidine is combined with Benperidol.
BenzatropineThe metabolism of Clonidine can be decreased when combined with Benzatropine.
BenzhydrocodoneThe risk or severity of hypotension can be increased when Benzhydrocodone is combined with Clonidine.
BenzocaineThe risk or severity of sedation can be increased when Clonidine is combined with Benzocaine.
BenzphetamineThe risk or severity of sedation can be increased when Clonidine is combined with Benzphetamine.
BenzthiazideThe therapeutic efficacy of Clonidine can be increased when used in combination with Benzthiazide.
BenzydamineThe therapeutic efficacy of Clonidine can be decreased when used in combination with Benzydamine.
Benzyl alcoholThe risk or severity of sedation can be increased when Clonidine is combined with Benzyl alcohol.
Benzylpenicilloyl polylysineClonidine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
BepridilThe risk or severity of hypotension can be increased when Clonidine is combined with Bepridil.
BeractantClonidine may increase the bradycardic activities of Beractant.
BerotralstatThe serum concentration of Clonidine can be increased when it is combined with Berotralstat.
BetamethasoneThe metabolism of Clonidine can be increased when combined with Betamethasone.
Betamethasone phosphateThe metabolism of Clonidine can be increased when combined with Betamethasone phosphate.
BetaxololThe risk or severity of hypotension can be increased when Clonidine is combined with Betaxolol.
BethanidineThe risk or severity of hypotension can be increased when Clonidine is combined with Bethanidine.
BexaroteneThe metabolism of Clonidine can be increased when combined with Bexarotene.
BicalutamideThe metabolism of Clonidine can be decreased when combined with Bicalutamide.
BifonazoleThe metabolism of Clonidine can be decreased when combined with Bifonazole.
BimatoprostClonidine may increase the hypotensive activities of Bimatoprost.
BimekizumabThe metabolism of Clonidine can be increased when combined with Bimekizumab.
BinimetinibThe metabolism of Binimetinib can be decreased when combined with Clonidine.
BiperidenThe metabolism of Clonidine can be decreased when combined with Biperiden.
BisoprololThe risk or severity of adverse effects can be increased when Bisoprolol is combined with Clonidine.
BoceprevirThe metabolism of Clonidine can be decreased when combined with Boceprevir.
BortezomibThe metabolism of Clonidine can be decreased when combined with Bortezomib.
BosentanThe risk or severity of hypotension can be increased when Clonidine is combined with Bosentan.
BosutinibThe metabolism of Clonidine can be decreased when combined with Bosutinib.
Botulinum toxin type AThe risk or severity of sedation can be increased when Clonidine is combined with Botulinum toxin type A.
Botulinum toxin type BThe risk or severity of sedation can be increased when Clonidine is combined with Botulinum toxin type B.
Brentuximab vedotinThe serum concentration of Clonidine can be increased when it is combined with Brentuximab vedotin.
BretyliumThe risk or severity of hypotension can be increased when Clonidine is combined with Bretylium.
BrexanoloneThe risk or severity of sedation can be increased when Clonidine is combined with Brexanolone.
BrexpiprazoleThe risk or severity of sedation can be increased when Clonidine is combined with Brexpiprazole.
BrimonidineBrimonidine may increase the antihypertensive activities of Clonidine.
BrivaracetamThe risk or severity of sedation can be increased when Clonidine is combined with Brivaracetam.
BromazepamThe risk or severity of sedation can be increased when Clonidine is combined with Bromazepam.
BromocriptineThe risk or severity of sedation can be increased when Clonidine is combined with Bromocriptine.
BromotheophyllineThe metabolism of Bromotheophylline can be decreased when combined with Clonidine.
BromperidolThe risk or severity of sedation can be increased when Clonidine is combined with Bromperidol.
BrompheniramineThe risk or severity of sedation can be increased when Clonidine is combined with Brompheniramine.
BuclizineThe risk or severity of Tachycardia can be increased when Buclizine is combined with Clonidine.
BudesonideThe metabolism of Clonidine can be increased when combined with Budesonide.
BumadizoneThe therapeutic efficacy of Clonidine can be decreased when used in combination with Bumadizone.
BumetanideThe risk or severity of adverse effects can be increased when Clonidine is combined with Bumetanide.
BupivacaineThe risk or severity of sedation can be increased when Clonidine is combined with Bupivacaine.
BuprenorphineThe risk or severity of sedation can be increased when Clonidine is combined with Buprenorphine.
BupropionThe risk or severity of sedation can be increased when Clonidine is combined with Bupropion.
BuspironeThe risk or severity of sedation can be increased when Clonidine is combined with Buspirone.
ButabarbitalThe risk or severity of sedation can be increased when Clonidine is combined with Butabarbital.
ButalbitalThe risk or severity of sedation can be increased when Clonidine is combined with Butalbital.
ButaperazineThe risk or severity of sedation can be increased when Clonidine is combined with Butaperazine.
ButobarbitalThe risk or severity of sedation can be increased when Clonidine is combined with Butobarbital.
ButorphanolThe risk or severity of sedation can be increased when Clonidine is combined with Butorphanol.
ButriptylineThe risk or severity of sedation can be increased when Clonidine is combined with Butriptyline.
ButylscopolamineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Butylscopolamine.
CabazitaxelThe metabolism of Cabazitaxel can be decreased when combined with Clonidine.
CabergolineThe risk or severity of sedation can be increased when Clonidine is combined with Cabergoline.
CaffeineThe metabolism of Clonidine can be decreased when combined with Caffeine.
CalcitriolThe metabolism of Clonidine can be increased when combined with Calcitriol.
CalfactantClonidine may increase the bradycardic activities of Calfactant.
CanagliflozinThe risk or severity of adverse effects can be increased when Clonidine is combined with Canagliflozin.
CanakinumabThe metabolism of Clonidine can be increased when combined with Canakinumab.
Candesartan cilexetilThe risk or severity of hypotension can be increased when Clonidine is combined with Candesartan cilexetil.
CandicidinThe serum concentration of Clonidine can be increased when it is combined with Candicidin.
CannabidiolThe risk or severity of sedation can be increased when Clonidine is combined with Cannabidiol.
CapmatinibThe serum concentration of Clonidine can be increased when it is combined with Capmatinib.
CapsaicinThe serum concentration of Clonidine can be increased when it is combined with Capsaicin.
CaptoprilThe risk or severity of hypotension can be increased when Clonidine is combined with Captopril.
CarbamazepineThe risk or severity of sedation can be increased when Clonidine is combined with Carbamazepine.
CarbetocinThe risk or severity of adverse effects can be increased when Clonidine is combined with Carbetocin.
CarbidopaThe risk or severity of hypotension can be increased when Carbidopa is combined with Clonidine.
CarbinoxamineThe risk or severity of sedation can be increased when Clonidine is combined with Carbinoxamine.
CariprazineThe risk or severity of sedation can be increased when Clonidine is combined with Cariprazine.
CarisoprodolThe risk or severity of sedation can be increased when Clonidine is combined with Carisoprodol.
CarmustineThe metabolism of Clonidine can be decreased when combined with Carmustine.
CarprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Carprofen.
CarteololCarteolol may increase the hypotensive activities of Clonidine.
CarvedilolThe risk or severity of hypotension can be increased when Clonidine is combined with Carvedilol.
CefradineThe metabolism of Clonidine can be increased when combined with Cefradine.
CelecoxibThe metabolism of Clonidine can be decreased when combined with Celecoxib.
CeliprololThe risk or severity of hypotension can be increased when Clonidine is combined with Celiprolol.
CenobamateThe serum concentration of Clonidine can be decreased when it is combined with Cenobamate.
CephalexinThe metabolism of Clonidine can be decreased when combined with Cephalexin.
CeritinibClonidine may increase the bradycardic activities of Ceritinib.
CerivastatinThe metabolism of Clonidine can be increased when combined with Cerivastatin.
Certolizumab pegolThe metabolism of Clonidine can be increased when combined with Certolizumab pegol.
CetirizineThe risk or severity of sedation can be increased when Clonidine is combined with Cetirizine.
CevimelineThe metabolism of Clonidine can be decreased when combined with Cevimeline.
Chloral hydrateThe risk or severity of sedation can be increased when Clonidine is combined with Chloral hydrate.
ChloramphenicolThe serum concentration of Clonidine can be increased when it is combined with Chloramphenicol.
ChlordiazepoxideThe risk or severity of sedation can be increased when Clonidine is combined with Chlordiazepoxide.
ChlormezanoneThe risk or severity of sedation can be increased when Clonidine is combined with Chlormezanone.
ChloroformThe therapeutic efficacy of Chloroform can be increased when used in combination with Clonidine.
ChloroprocaineThe risk or severity of sedation can be increased when Clonidine is combined with Chloroprocaine.
ChloroquineThe metabolism of Clonidine can be decreased when combined with Chloroquine.
ChlorothiazideThe risk or severity of hypotension can be increased when Clonidine is combined with Chlorothiazide.
ChlorpheniramineThe risk or severity of sedation can be increased when Clonidine is combined with Chlorpheniramine.
ChlorpromazineThe risk or severity of sedation can be increased when Clonidine is combined with Chlorpromazine.
ChlorprothixeneThe risk or severity of sedation can be increased when Clonidine is combined with Chlorprothixene.
ChlorzoxazoneThe risk or severity of sedation can be increased when Clonidine is combined with Chlorzoxazone.
CholecalciferolThe metabolism of Clonidine can be decreased when combined with Cholecalciferol.
Choline magnesium trisalicylateThe therapeutic efficacy of Clonidine can be decreased when used in combination with Choline magnesium trisalicylate.
CiclesonideThe metabolism of Clonidine can be decreased when combined with Ciclesonide.
CilazaprilThe risk or severity of hypotension can be increased when Clonidine is combined with Cilazapril.
CilostazolThe metabolism of Clonidine can be decreased when combined with Cilostazol.
CimetidineThe metabolism of Clonidine can be decreased when combined with Cimetidine.
CinacalcetThe metabolism of Clonidine can be decreased when combined with Cinacalcet.
CinchocaineThe risk or severity of sedation can be increased when Clonidine is combined with Cinchocaine.
CinnarizineClonidine may increase the atrioventricular blocking (AV block) activities of Cinnarizine.
CinoxacinThe metabolism of Clonidine can be decreased when combined with Cinoxacin.
CiprofloxacinThe metabolism of Clonidine can be decreased when combined with Ciprofloxacin.
CisaprideThe risk or severity of sedation can be increased when Clonidine is combined with Cisapride.
CisatracuriumThe risk or severity of sedation can be increased when Clonidine is combined with Cisatracurium.
CitalopramThe risk or severity of sedation can be increased when Clonidine is combined with Citalopram.
ClarithromycinThe metabolism of Clonidine can be decreased when combined with Clarithromycin.
ClemastineThe risk or severity of sedation can be increased when Clonidine is combined with Clemastine.
ClenbuterolClenbuterol may decrease the antihypertensive activities of Clonidine.
ClevidipineClonidine may increase the atrioventricular blocking (AV block) activities of Clevidipine.
ClidiniumThe risk or severity of sedation can be increased when Clonidine is combined with Clidinium.
ClindamycinThe metabolism of Clonidine can be decreased when combined with Clindamycin.
ClobazamThe risk or severity of sedation can be increased when Clonidine is combined with Clobazam.
Clobetasol propionateThe metabolism of Clonidine can be increased when combined with Clobetasol propionate.
ClofarabineThe risk or severity of adverse effects can be increased when Clonidine is combined with Clofarabine.
ClofazimineThe serum concentration of Clonidine can be increased when it is combined with Clofazimine.
ClofibrateThe metabolism of Clonidine can be increased when combined with Clofibrate.
ClomipramineThe risk or severity of sedation can be increased when Clonidine is combined with Clomipramine.
ClonazepamThe risk or severity of sedation can be increased when Clonidine is combined with Clonazepam.
ClopidogrelThe metabolism of Clonidine can be decreased when combined with Clopidogrel.
Clorazepic acidThe risk or severity of sedation can be increased when Clonidine is combined with Clorazepic acid.
ClothiapineThe risk or severity of sedation can be increased when Clonidine is combined with Clothiapine.
ClotiazepamThe risk or severity of sedation can be increased when Clonidine is combined with Clotiazepam.
ClozapineThe risk or severity of sedation can be increased when Clonidine is combined with Clozapine.
CobicistatThe metabolism of Clonidine can be decreased when combined with Cobicistat.
CobimetinibThe metabolism of Clonidine can be decreased when combined with Cobimetinib.
CocaineThe metabolism of Clonidine can be decreased when combined with Cocaine.
CodeineThe risk or severity of sedation can be increased when Clonidine is combined with Codeine.
ConivaptanThe metabolism of Clonidine can be decreased when combined with Conivaptan.
Conjugated estrogensThe metabolism of Clonidine can be decreased when combined with Conjugated estrogens.
CopanlisibThe metabolism of Copanlisib can be decreased when combined with Clonidine.
CorticotropinThe metabolism of Clonidine can be increased when combined with Corticotropin.
Cortisone acetateThe metabolism of Clonidine can be increased when combined with Cortisone acetate.
CrizotinibThe metabolism of Clonidine can be decreased when combined with Crizotinib.
CryptenamineThe risk or severity of hypotension can be increased when Clonidine is combined with Cryptenamine.
CurcuminThe metabolism of Clonidine can be decreased when combined with Curcumin.
CyclandelateClonidine may increase the atrioventricular blocking (AV block) activities of Cyclandelate.
CyclizineThe risk or severity of sedation can be increased when Clonidine is combined with Cyclizine.
CyclobenzaprineThe risk or severity of sedation can be increased when Clonidine is combined with Cyclobenzaprine.
CyclopenthiazideThe risk or severity of hypotension can be increased when Clonidine is combined with Cyclopenthiazide.
CyclophosphamideThe metabolism of Clonidine can be increased when combined with Cyclophosphamide.
CyclosporineThe metabolism of Clonidine can be decreased when combined with Cyclosporine.
CyclothiazideThe risk or severity of hypotension can be increased when Clonidine is combined with Cyclothiazide.
CycrimineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Cycrimine.
CyproheptadineThe risk or severity of sedation can be increased when Clonidine is combined with Cyproheptadine.
Cyproterone acetateThe risk or severity of sedation can be increased when Cyproterone acetate is combined with Clonidine.
DabrafenibThe serum concentration of Clonidine can be decreased when it is combined with Dabrafenib.
DacarbazineThe metabolism of Dacarbazine can be decreased when combined with Clonidine.
DaclatasvirThe metabolism of Clonidine can be decreased when combined with Daclatasvir.
DacomitinibThe metabolism of Clonidine can be decreased when combined with Dacomitinib.
DalfopristinThe metabolism of Clonidine can be decreased when combined with Dalfopristin.
DanazolThe metabolism of Clonidine can be decreased when combined with Danazol.
DantroleneThe risk or severity of sedation can be increased when Clonidine is combined with Dantrolene.
DapagliflozinThe risk or severity of adverse effects can be increased when Clonidine is combined with Dapagliflozin.
DapsoneThe metabolism of Clonidine can be decreased when combined with Dapsone.
DaridorexantThe risk or severity of sedation can be increased when Clonidine is combined with Daridorexant.
DarifenacinThe metabolism of Clonidine can be decreased when combined with Darifenacin.
DarunavirThe serum concentration of Clonidine can be increased when it is combined with Darunavir.
DasabuvirThe metabolism of Clonidine can be decreased when combined with Dasabuvir.
DasatinibThe metabolism of Clonidine can be decreased when combined with Dasatinib.
DasiglucagonThe risk or severity of hypotension can be increased when Clonidine is combined with Dasiglucagon.
DaunorubicinThe serum concentration of Clonidine can be increased when it is combined with Daunorubicin.
DebrisoquineThe risk or severity of hypotension can be increased when Clonidine is combined with Debrisoquine.
DecamethoniumThe risk or severity of sedation can be increased when Clonidine is combined with Decamethonium.
DeferasiroxThe serum concentration of Clonidine can be increased when it is combined with Deferasirox.
DeflazacortThe metabolism of Clonidine can be increased when combined with Deflazacort.
DelavirdineThe metabolism of Clonidine can be decreased when combined with Delavirdine.
DeserpidineThe risk or severity of hypotension can be increased when Clonidine is combined with Deserpidine.
DesfluraneThe risk or severity of sedation can be increased when Clonidine is combined with Desflurane.
DesipramineThe risk or severity of sedation can be increased when Clonidine is combined with Desipramine.
DeslanosideClonidine may increase the atrioventricular blocking (AV block) activities of Deslanoside.
DesloratadineThe risk or severity of sedation can be increased when Clonidine is combined with Desloratadine.
DesmopressinDesmopressin may decrease the antihypertensive activities of Clonidine.
DesogestrelThe risk or severity of sedation can be increased when Desogestrel is combined with Clonidine.
DesvenlafaxineThe risk or severity of sedation can be increased when Clonidine is combined with Desvenlafaxine.
DeutetrabenazineThe metabolism of Clonidine can be decreased when combined with Deutetrabenazine.
DexamethasoneThe metabolism of Clonidine can be increased when combined with Dexamethasone.
Dexamethasone acetateThe metabolism of Clonidine can be increased when combined with Dexamethasone acetate.
DexbrompheniramineThe risk or severity of sedation can be increased when Clonidine is combined with Dexbrompheniramine.
Dexchlorpheniramine maleateThe metabolism of Clonidine can be decreased when combined with Dexchlorpheniramine maleate.
DexfenfluramineThe metabolism of Clonidine can be decreased when combined with Dexfenfluramine.
DexibuprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Dexibuprofen.
DexketoprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Dexketoprofen.
DexmedetomidineThe risk or severity of sedation can be increased when Clonidine is combined with Dexmedetomidine.
DexmethylphenidateThe risk or severity of sedation can be increased when Clonidine is combined with Dexmethylphenidate.
DextroamphetamineThe metabolism of Clonidine can be decreased when combined with Dextroamphetamine.
DextromethorphanThe risk or severity of sedation can be increased when Clonidine is combined with Dextromethorphan.
DextropropoxypheneThe risk or severity of sedation can be increased when Clonidine is combined with Dextropropoxyphene.
DezocineThe risk or severity of sedation can be increased when Clonidine is combined with Dezocine.
DiacereinThe metabolism of Clonidine can be decreased when combined with Diacerein.
DiamorphineThe risk or severity of sedation can be increased when Clonidine is combined with Diamorphine.
DiazepamThe risk or severity of sedation can be increased when Clonidine is combined with Diazepam.
DiazoxideDiazoxide may increase the hypotensive activities of Clonidine.
DibenzepinThe risk or severity of sedation can be increased when Clonidine is combined with Dibenzepin.
DichloralphenazoneThe risk or severity of sedation can be increased when Clonidine is combined with Dichloralphenazone.
DiclofenacThe therapeutic efficacy of Clonidine can be decreased when used in combination with Diclofenac.
DiclofenamideThe risk or severity of adverse effects can be increased when Clonidine is combined with Diclofenamide.
DicloxacillinThe metabolism of Clonidine can be increased when combined with Dicloxacillin.
DicyclomineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Dicyclomine.
DienogestThe risk or severity of sedation can be increased when Dienogest is combined with Clonidine.
DiethylpropionThe risk or severity of sedation can be increased when Clonidine is combined with Diethylpropion.
DiethylstilbestrolThe serum concentration of Clonidine can be increased when it is combined with Diethylstilbestrol.
DifenoxinThe risk or severity of sedation can be increased when Clonidine is combined with Difenoxin.
DiflunisalThe therapeutic efficacy of Clonidine can be decreased when used in combination with Diflunisal.
DifluocortoloneThe metabolism of Clonidine can be increased when combined with Difluocortolone.
DigitoxinClonidine may increase the atrioventricular blocking (AV block) activities of Digitoxin.
DigoxinClonidine may increase the atrioventricular blocking (AV block) activities of Digoxin.
DihydralazineThe risk or severity of hypotension can be increased when Clonidine is combined with Dihydralazine.
DihydrocodeineThe risk or severity of sedation can be increased when Clonidine is combined with Dihydrocodeine.
DihydroergocornineDihydroergocornine may increase the hypertensive and vasoconstricting activities of Clonidine.
DihydroergocristineDihydroergocristine may increase the hypertensive and vasoconstricting activities of Clonidine.
DihydroergotamineThe risk or severity of sedation can be increased when Clonidine is combined with Dihydroergotamine.
DiltiazemDiltiazem may increase the atrioventricular blocking (AV block) activities of Clonidine.
DimenhydrinateThe risk or severity of sedation can be increased when Clonidine is combined with Dimenhydrinate.
Dimethyl sulfoxideThe serum concentration of Clonidine can be increased when it is combined with Dimethyl sulfoxide.
DimetindeneThe risk or severity of Tachycardia can be increased when Clonidine is combined with Dimetindene.
DinutuximabThe risk or severity of adverse effects can be increased when Clonidine is combined with Dinutuximab.
DiosminThe serum concentration of Clonidine can be increased when it is combined with Diosmin.
DiphemanilThe risk or severity of Tachycardia can be increased when Clonidine is combined with Diphemanil.
DiphenhydramineThe risk or severity of sedation can be increased when Clonidine is combined with Diphenhydramine.
DiphenidolThe risk or severity of Tachycardia can be increased when Clonidine is combined with Diphenidol.
DiphenoxylateThe risk or severity of sedation can be increased when Clonidine is combined with Diphenoxylate.
DipyridamoleDipyridamole may increase the antihypertensive activities of Clonidine.
DisopyramideThe metabolism of Clonidine can be decreased when combined with Disopyramide.
DisulfiramThe metabolism of Clonidine can be decreased when combined with Disulfiram.
DL-MethylephedrineDL-Methylephedrine may decrease the antihypertensive activities of Clonidine.
DobutamineDobutamine may decrease the antihypertensive activities of Clonidine.
DocetaxelThe serum concentration of Clonidine can be increased when it is combined with Docetaxel.
DolasetronThe risk or severity of sedation can be increased when Clonidine is combined with Dolasetron.
DomperidoneThe metabolism of Clonidine can be decreased when combined with Domperidone.
DonepezilThe risk or severity of sedation can be increased when Clonidine is combined with Donepezil.
DopamineDopamine may decrease the antihypertensive activities of Clonidine.
DopexamineDopexamine may decrease the antihypertensive activities of Clonidine.
DoravirineThe metabolism of Clonidine can be decreased when combined with Doravirine.
DorzolamideClonidine may increase the hypotensive activities of Dorzolamide.
DosulepinThe risk or severity of sedation can be increased when Clonidine is combined with Dosulepin.
DoxacuriumThe risk or severity of sedation can be increased when Clonidine is combined with Doxacurium.
DoxapramDoxapram may decrease the antihypertensive activities of Clonidine.
DoxazosinThe risk or severity of hypotension can be increased when Clonidine is combined with Doxazosin.
DoxepinThe risk or severity of sedation can be increased when Clonidine is combined with Doxepin.
DoxorubicinThe serum concentration of Clonidine can be increased when it is combined with Doxorubicin.
DoxylamineThe risk or severity of sedation can be increased when Clonidine is combined with Doxylamine.
DronabinolThe risk or severity of sedation can be increased when Clonidine is combined with Dronabinol.
DronedaroneThe serum concentration of Clonidine can be increased when it is combined with Dronedarone.
DroperidolThe risk or severity of sedation can be increased when Clonidine is combined with Droperidol.
DrospirenoneThe risk or severity of sedation can be increased when Drospirenone is combined with Clonidine.
DroxidopaDroxidopa may decrease the antihypertensive activities of Clonidine.
DuloxetineThe risk or severity of sedation can be increased when Clonidine is combined with Duloxetine.
DutasterideThe metabolism of Clonidine can be decreased when combined with Dutasteride.
DuvelisibThe metabolism of Clonidine can be decreased when combined with Duvelisib.
DyclonineThe risk or severity of sedation can be increased when Clonidine is combined with Dyclonine.
EbastineThe metabolism of Clonidine can be decreased when combined with Ebastine.
EchinaceaThe metabolism of Clonidine can be increased when combined with Echinacea.
EfavirenzThe risk or severity of sedation can be increased when Clonidine is combined with Efavirenz.
ElagolixThe metabolism of Clonidine can be decreased when combined with Elagolix.
ElbasvirThe metabolism of Clonidine can be decreased when combined with Elbasvir.
EletriptanThe risk or severity of sedation can be increased when Clonidine is combined with Eletriptan.
ElexacaftorThe metabolism of Clonidine can be decreased when combined with Elexacaftor.
EliglustatThe metabolism of Clonidine can be decreased when combined with Eliglustat.
EltrombopagThe metabolism of Eltrombopag can be decreased when combined with Clonidine.
EluxadolineThe risk or severity of hypotension can be increased when Eluxadoline is combined with Clonidine.
ElvitegravirThe metabolism of Clonidine can be decreased when combined with Elvitegravir.
EmapalumabThe metabolism of Clonidine can be increased when combined with Emapalumab.
EmpagliflozinThe risk or severity of adverse effects can be increased when Clonidine is combined with Empagliflozin.
EnalaprilThe risk or severity of hypotension can be increased when Clonidine is combined with Enalapril.
EnalaprilatThe risk or severity of hypotension can be increased when Clonidine is combined with Enalaprilat.
EnasidenibThe metabolism of Clonidine can be increased when combined with Enasidenib.
EncainideThe metabolism of Clonidine can be decreased when combined with Encainide.
EncorafenibThe metabolism of Clonidine can be increased when combined with Encorafenib.
EnfluraneThe risk or severity of sedation can be increased when Clonidine is combined with Enflurane.
EnoxacinThe metabolism of Clonidine can be decreased when combined with Enoxacin.
EntacaponeThe risk or severity of sedation can be increased when Clonidine is combined with Entacapone.
EntecavirThe metabolism of Clonidine can be decreased when combined with Entecavir.
EnzalutamideThe serum concentration of Clonidine can be decreased when it is combined with Enzalutamide.
EpcoritamabThe serum concentration of Clonidine can be increased when it is combined with Epcoritamab.
EphedrineEphedrine may decrease the antihypertensive activities of Clonidine.
EpinastineThe risk or severity of sedation can be increased when Clonidine is combined with Epinastine.
EpinephrineThe serum concentration of Clonidine can be increased when it is combined with Epinephrine.
EplerenoneThe risk or severity of hypotension can be increased when Clonidine is combined with Eplerenone.
EpoprostenolThe risk or severity of hypotension can be increased when Clonidine is combined with Epoprostenol.
EprosartanThe risk or severity of hypotension can be increased when Clonidine is combined with Eprosartan.
ErdafitinibThe serum concentration of Clonidine can be increased when it is combined with Erdafitinib.
Ergoloid mesylateThe risk or severity of sedation can be increased when Clonidine is combined with Ergoloid mesylate.
ErgometrineThe risk or severity of sedation can be increased when Clonidine is combined with Ergometrine.
ErgotamineThe risk or severity of sedation can be increased when Clonidine is combined with Ergotamine.
ErlotinibThe serum concentration of Clonidine can be increased when it is combined with Erlotinib.
ErythromycinThe serum concentration of Clonidine can be increased when it is combined with Erythromycin.
EscitalopramThe risk or severity of sedation can be increased when Clonidine is combined with Escitalopram.
EsketamineThe risk or severity of sedation can be increased when Clonidine is combined with Esketamine.
EslicarbazepineThe risk or severity of sedation can be increased when Clonidine is combined with Eslicarbazepine.
Eslicarbazepine acetateThe risk or severity of sedation can be increased when Clonidine is combined with Eslicarbazepine acetate.
EsmololThe risk or severity of hypotension can be increased when Clonidine is combined with Esmolol.
EstazolamThe risk or severity of sedation can be increased when Clonidine is combined with Estazolam.
EstetrolThe risk or severity of sedation can be increased when Estetrol is combined with Clonidine.
EstradiolThe risk or severity of sedation can be increased when Estradiol is combined with Clonidine.
Estradiol acetateThe metabolism of Clonidine can be increased when combined with Estradiol acetate.
Estradiol benzoateThe metabolism of Clonidine can be increased when combined with Estradiol benzoate.
Estradiol cypionateThe metabolism of Clonidine can be increased when combined with Estradiol cypionate.
Estradiol dienanthateThe metabolism of Clonidine can be increased when combined with Estradiol dienanthate.
Estradiol valerateThe metabolism of Clonidine can be increased when combined with Estradiol valerate.
Estrone sulfateThe metabolism of Clonidine can be decreased when combined with Estrone sulfate.
EszopicloneThe risk or severity of sedation can be increased when Clonidine is combined with Eszopiclone.
Etacrynic acidThe risk or severity of adverse effects can be increased when Clonidine is combined with Etacrynic acid.
EtafedrineEtafedrine may decrease the antihypertensive activities of Clonidine.
EtanerceptThe metabolism of Clonidine can be increased when combined with Etanercept.
EthambutolThe metabolism of Clonidine can be decreased when combined with Ethambutol.
EthanolEthanol may increase the central nervous system depressant (CNS depressant) activities of Clonidine.
EthchlorvynolThe risk or severity of sedation can be increased when Clonidine is combined with Ethchlorvynol.
EthinylestradiolThe risk or severity of sedation can be increased when Ethinylestradiol is combined with Clonidine.
EthosuximideThe risk or severity of sedation can be increased when Clonidine is combined with Ethosuximide.
EthotoinThe risk or severity of sedation can be increased when Clonidine is combined with Ethotoin.
Ethynodiol diacetateThe risk or severity of sedation can be increased when Ethynodiol diacetate is combined with Clonidine.
EtilefrineEtilefrine may decrease the antihypertensive activities of Clonidine.
EtodolacThe therapeutic efficacy of Clonidine can be decreased when used in combination with Etodolac.
EtomidateThe risk or severity of sedation can be increased when Clonidine is combined with Etomidate.
EtoposideThe metabolism of Etoposide can be decreased when combined with Clonidine.
EtoricoxibThe serum concentration of Clonidine can be increased when it is combined with Etoricoxib.
EtravirineThe metabolism of Clonidine can be increased when combined with Etravirine.
EverolimusThe metabolism of Clonidine can be decreased when combined with Everolimus.
EzogabineThe risk or severity of sedation can be increased when Clonidine is combined with Ezogabine.
FamotidineThe metabolism of Clonidine can be decreased when combined with Famotidine.
FedratinibThe serum concentration of Clonidine can be increased when it is combined with Fedratinib.
FelbamateThe risk or severity of sedation can be increased when Clonidine is combined with Felbamate.
FelodipineThe risk or severity of hypotension can be increased when Clonidine is combined with Felodipine.
FenbufenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Fenbufen.
FenfluramineThe risk or severity of sedation can be increased when Clonidine is combined with Fenfluramine.
FenofibrateThe metabolism of Clonidine can be decreased when combined with Fenofibrate.
FenoldopamThe risk or severity of hypotension can be increased when Clonidine is combined with Fenoldopam.
FenoprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Fenoprofen.
FenoterolFenoterol may decrease the antihypertensive activities of Clonidine.
FentanylThe risk or severity of sedation can be increased when Clonidine is combined with Fentanyl.
FesoterodineThe metabolism of Clonidine can be decreased when combined with Fesoterodine.
FexinidazoleThe risk or severity of adverse effects can be increased when Clonidine is combined with Fexinidazole.
FezolinetantThe metabolism of Fezolinetant can be decreased when combined with Clonidine.
FilgotinibThe serum concentration of Clonidine can be increased when it is combined with Filgotinib.
FinasterideThe metabolism of Clonidine can be decreased when combined with Finasteride.
FingolimodClonidine may increase the bradycardic activities of Fingolimod.
FlavoxateThe risk or severity of Tachycardia can be increased when Clonidine is combined with Flavoxate.
FlecainideThe metabolism of Clonidine can be decreased when combined with Flecainide.
FlibanserinThe risk or severity of sedation can be increased when Clonidine is combined with Flibanserin.
FloctafenineThe therapeutic efficacy of Clonidine can be decreased when used in combination with Floctafenine.
FlucloxacillinThe metabolism of Clonidine can be increased when combined with Flucloxacillin.
FluconazoleThe metabolism of Clonidine can be decreased when combined with Fluconazole.
FlunarizineThe risk or severity of sedation can be increased when Clonidine is combined with Flunarizine.
FlunisolideThe metabolism of Clonidine can be increased when combined with Flunisolide.
FlunitrazepamThe risk or severity of sedation can be increased when Clonidine is combined with Flunitrazepam.
Fluocinolone acetonideThe metabolism of Clonidine can be increased when combined with Fluocinolone acetonide.
FluocinonideThe metabolism of Clonidine can be increased when combined with Fluocinonide.
FluocortoloneThe metabolism of Clonidine can be increased when combined with Fluocortolone.
FluorouracilThe metabolism of Clonidine can be decreased when combined with Fluorouracil.
FluoxetineThe risk or severity of sedation can be increased when Clonidine is combined with Fluoxetine.
FlupentixolThe risk or severity of sedation can be increased when Clonidine is combined with Flupentixol.
FluphenazineThe risk or severity of adverse effects can be increased when Fluphenazine is combined with Clonidine.
FlurazepamThe risk or severity of sedation can be increased when Clonidine is combined with Flurazepam.
FlurbiprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Flurbiprofen.
FluspirileneThe risk or severity of sedation can be increased when Clonidine is combined with Fluspirilene.
FlutamideThe metabolism of Clonidine can be decreased when combined with Flutamide.
FluticasoneThe metabolism of Clonidine can be increased when combined with Fluticasone.
Fluticasone furoateThe metabolism of Clonidine can be decreased when combined with Fluticasone furoate.
Fluticasone propionateThe risk or severity of sedation can be increased when Clonidine is combined with Fluticasone propionate.
FluvastatinThe metabolism of Clonidine can be decreased when combined with Fluvastatin.
FluvoxamineThe risk or severity of sedation can be increased when Clonidine is combined with Fluvoxamine.
FormestaneThe metabolism of Clonidine can be increased when combined with Formestane.
FormoterolClonidine may increase the sympathomimetic activities of Formoterol.
FosamprenavirThe serum concentration of Clonidine can be increased when it is combined with Fosamprenavir.
FosaprepitantThe metabolism of Clonidine can be increased when combined with Fosaprepitant.
FosinoprilThe risk or severity of hypotension can be increased when Clonidine is combined with Fosinopril.
FosnetupitantThe metabolism of Clonidine can be decreased when combined with Fosnetupitant.
FosphenytoinThe risk or severity of sedation can be increased when Clonidine is combined with Fosphenytoin.
FospropofolThe risk or severity of sedation can be increased when Clonidine is combined with Fospropofol.
FostamatinibThe serum concentration of Clonidine can be increased when it is combined with Fostamatinib.
FrovatriptanThe risk or severity of sedation can be increased when Clonidine is combined with Frovatriptan.
FruquintinibThe metabolism of Clonidine can be decreased when combined with Fruquintinib.
FurosemideThe risk or severity of hypotension can be increased when Clonidine is combined with Furosemide.
Fusidic acidThe metabolism of Clonidine can be decreased when combined with Fusidic acid.
GabapentinThe risk or severity of sedation can be increased when Clonidine is combined with Gabapentin.
Gabapentin enacarbilThe risk or severity of sedation can be increased when Clonidine is combined with Gabapentin enacarbil.
GalantamineThe metabolism of Clonidine can be decreased when combined with Galantamine.
Gallamine triethiodideThe risk or severity of sedation can be increased when Clonidine is combined with Gallamine triethiodide.
gamma-Hydroxybutyric acidThe risk or severity of sedation can be increased when Clonidine is combined with gamma-Hydroxybutyric acid.
GanaxoloneThe risk or severity of sedation can be increased when Clonidine is combined with Ganaxolone.
GatifloxacinThe metabolism of Clonidine can be decreased when combined with Gatifloxacin.
GefitinibThe metabolism of Clonidine can be decreased when combined with Gefitinib.
GemfibrozilThe metabolism of Clonidine can be decreased when combined with Gemfibrozil.
GemifloxacinThe metabolism of Clonidine can be decreased when combined with Gemifloxacin.
GepironeThe risk or severity of sedation can be increased when Clonidine is combined with Gepirone.
GestrinoneThe risk or severity of sedation can be increased when Gestrinone is combined with Clonidine.
GilteritinibThe metabolism of Clonidine can be decreased when combined with Gilteritinib.
Ginkgo bilobaThe metabolism of Clonidine can be decreased when combined with Ginkgo biloba.
GivinostatThe serum concentration of Clonidine can be increased when it is combined with Givinostat.
GivosiranThe serum concentration of Clonidine can be increased when it is combined with Givosiran.
GlecaprevirThe metabolism of Clonidine can be decreased when combined with Glecaprevir.
GlofitamabThe serum concentration of Clonidine can be increased when it is combined with Glofitamab.
GlutethimideThe risk or severity of sedation can be increased when Clonidine is combined with Glutethimide.
GlyburideThe metabolism of Clonidine can be decreased when combined with Glyburide.
Glycerol phenylbutyrateThe metabolism of Clonidine can be increased when combined with Glycerol phenylbutyrate.
Glycol salicylateThe therapeutic efficacy of Clonidine can be decreased when used in combination with Glycol salicylate.
GlycopyrroniumThe risk or severity of Tachycardia can be increased when Clonidine is combined with Glycopyrronium.
GolimumabThe metabolism of Clonidine can be increased when combined with Golimumab.
GranisetronThe risk or severity of sedation can be increased when Clonidine is combined with Granisetron.
GrapefruitThe serum concentration of Clonidine can be increased when it is combined with Grapefruit.
GrepafloxacinThe metabolism of Clonidine can be decreased when combined with Grepafloxacin.
GriseofulvinThe metabolism of Clonidine can be increased when combined with Griseofulvin.
GuanabenzThe risk or severity of hypotension can be increased when Clonidine is combined with Guanabenz.
GuanadrelThe risk or severity of hypotension can be increased when Clonidine is combined with Guanadrel.
GuanethidineThe risk or severity of hypotension can be increased when Clonidine is combined with Guanethidine.
GuanfacineThe risk or severity of sedation can be increased when Clonidine is combined with Guanfacine.
GuanoxanThe risk or severity of hypotension can be increased when Clonidine is combined with Guanoxan.
HalazepamThe risk or severity of sedation can be increased when Clonidine is combined with Halazepam.
HalofantrineThe metabolism of Clonidine can be decreased when combined with Halofantrine.
HaloperidolThe risk or severity of sedation can be increased when Clonidine is combined with Haloperidol.
HalothaneThe risk or severity of sedation can be increased when Clonidine is combined with Halothane.
HexafluroniumThe risk or severity of sedation can be increased when Clonidine is combined with Hexafluronium.
HexocycliumThe risk or severity of Tachycardia can be increased when Clonidine is combined with Hexocyclium.
Homatropine methylbromideThe risk or severity of Tachycardia can be increased when Clonidine is combined with Homatropine methylbromide.
HyaluronidaseThe risk or severity of adverse effects can be increased when Hyaluronidase is combined with Clonidine.
Hyaluronidase (human recombinant)The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Clonidine.
Hyaluronidase (ovine)The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Clonidine.
HydralazineThe risk or severity of hypotension can be increased when Clonidine is combined with Hydralazine.
HydrochlorothiazideThe risk or severity of hypotension can be increased when Clonidine is combined with Hydrochlorothiazide.
HydrocodoneThe risk or severity of sedation can be increased when Clonidine is combined with Hydrocodone.
HydrocortamateThe metabolism of Clonidine can be increased when combined with Hydrocortamate.
HydrocortisoneThe metabolism of Clonidine can be increased when combined with Hydrocortisone.
Hydrocortisone acetateThe metabolism of Clonidine can be increased when combined with Hydrocortisone acetate.
Hydrocortisone butyrateThe metabolism of Clonidine can be increased when combined with Hydrocortisone butyrate.
Hydrocortisone cypionateThe metabolism of Clonidine can be decreased when combined with Hydrocortisone cypionate.
Hydrocortisone phosphateThe metabolism of Clonidine can be decreased when combined with Hydrocortisone phosphate.
Hydrocortisone succinateThe metabolism of Clonidine can be increased when combined with Hydrocortisone succinate.
HydroflumethiazideThe risk or severity of hypotension can be increased when Clonidine is combined with Hydroflumethiazide.
HydromorphoneThe risk or severity of sedation can be increased when Clonidine is combined with Hydromorphone.
HydroxychloroquineThe metabolism of Clonidine can be decreased when combined with Hydroxychloroquine.
Hydroxyprogesterone caproateThe metabolism of Clonidine can be decreased when combined with Hydroxyprogesterone caproate.
HydroxyzineThe risk or severity of sedation can be increased when Clonidine is combined with Hydroxyzine.
HyoscyamineThe risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Clonidine.
IbrutinibThe metabolism of Clonidine can be decreased when combined with Ibrutinib.
IbuprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Ibuprofen.
IcosapentThe therapeutic efficacy of Clonidine can be decreased when used in combination with Icosapent.
IdarubicinThe metabolism of Clonidine can be decreased when combined with Idarubicin.
IdelalisibThe metabolism of Clonidine can be decreased when combined with Idelalisib.
IfosfamideThe metabolism of Clonidine can be increased when combined with Ifosfamide.
IloperidoneThe risk or severity of sedation can be increased when Clonidine is combined with Iloperidone.
IloprostIloprost may increase the hypotensive activities of Clonidine.
ImatinibThe serum concentration of Clonidine can be increased when it is combined with Imatinib.
ImipramineThe risk or severity of sedation can be increased when Clonidine is combined with Imipramine.
IndacaterolIndacaterol may decrease the antihypertensive activities of Clonidine.
IndapamideThe risk or severity of hypotension can be increased when Clonidine is combined with Indapamide.
IndinavirThe metabolism of Clonidine can be decreased when combined with Indinavir.
IndomethacinThe therapeutic efficacy of Clonidine can be decreased when used in combination with Indomethacin.
IndoraminThe risk or severity of hypotension can be increased when Clonidine is combined with Indoramin.
InfigratinibThe metabolism of Clonidine can be decreased when combined with Infigratinib.
InfliximabThe metabolism of Clonidine can be increased when combined with Infliximab.
Insulin aspartThe therapeutic efficacy of Insulin aspart can be increased when used in combination with Clonidine.
Insulin beefThe therapeutic efficacy of Insulin beef can be increased when used in combination with Clonidine.
Insulin degludecThe therapeutic efficacy of Insulin degludec can be increased when used in combination with Clonidine.
Insulin detemirThe therapeutic efficacy of Insulin detemir can be increased when used in combination with Clonidine.
Insulin glargineThe therapeutic efficacy of Insulin glargine can be increased when used in combination with Clonidine.
Insulin glulisineThe therapeutic efficacy of Insulin glulisine can be increased when used in combination with Clonidine.
Insulin humanThe therapeutic efficacy of Insulin human can be increased when used in combination with Clonidine.
Insulin lisproThe therapeutic efficacy of Insulin lispro can be increased when used in combination with Clonidine.
Insulin porkThe therapeutic efficacy of Insulin pork can be increased when used in combination with Clonidine.
Interferon alfa-2aThe metabolism of Clonidine can be decreased when combined with Interferon alfa-2a.
Interferon alfa-2bThe metabolism of Clonidine can be decreased when combined with Interferon alfa-2b.
Interferon alfa-n1The metabolism of Clonidine can be decreased when combined with Interferon alfa-n1.
Interferon alfa-n3The metabolism of Clonidine can be decreased when combined with Interferon alfa-n3.
Interferon alfacon-1The metabolism of Clonidine can be decreased when combined with Interferon alfacon-1.
Interferon beta-1aThe metabolism of Clonidine can be decreased when combined with Interferon beta-1a.
Interferon beta-1bThe metabolism of Clonidine can be decreased when combined with Interferon beta-1b.
Interferon gamma-1bThe metabolism of Clonidine can be decreased when combined with Interferon gamma-1b.
IobenguaneThe therapeutic efficacy of Iobenguane can be decreased when used in combination with Clonidine.
Iofetamine I-123Iofetamine I-123 may decrease the antihypertensive activities of Clonidine.
IpecacThe metabolism of Clonidine can be decreased when combined with Ipecac.
IpratropiumThe risk or severity of Tachycardia can be increased when Ipratropium is combined with Clonidine.
IptacopanThe metabolism of Clonidine can be decreased when combined with Iptacopan.
IrbesartanThe risk or severity of hypotension can be increased when Clonidine is combined with Irbesartan.
IrinotecanThe metabolism of Clonidine can be decreased when combined with Irinotecan.
IsavuconazoleThe metabolism of Clonidine can be increased when combined with Isavuconazole.
IsavuconazoniumThe metabolism of Clonidine can be increased when combined with Isavuconazonium.
IsocarboxazidThe risk or severity of sedation can be increased when Clonidine is combined with Isocarboxazid.
IsoetharineIsoetharine may decrease the antihypertensive activities of Clonidine.
IsofluraneThe risk or severity of sedation can be increased when Clonidine is combined with Isoflurane.
IsomethepteneIsometheptene may decrease the antihypertensive activities of Clonidine.
IsoniazidThe metabolism of Clonidine can be decreased when combined with Isoniazid.
IsoprenalineIsoprenaline may decrease the antihypertensive activities of Clonidine.
IsopropamideThe risk or severity of Tachycardia can be increased when Clonidine is combined with Isopropamide.
Isosorbide dinitrateThe risk or severity of adverse effects can be increased when Clonidine is combined with Isosorbide dinitrate.
Isosorbide mononitrateThe risk or severity of adverse effects can be increased when Clonidine is combined with Isosorbide mononitrate.
IsoxicamThe therapeutic efficacy of Clonidine can be decreased when used in combination with Isoxicam.
IsoxsuprineIsoxsuprine may decrease the antihypertensive activities of Clonidine.
IsradipineThe risk or severity of hypotension can be increased when Clonidine is combined with Isradipine.
IstradefyllineThe metabolism of Clonidine can be decreased when combined with Istradefylline.
ItraconazoleThe metabolism of Clonidine can be decreased when combined with Itraconazole.
IvabradineClonidine may increase the bradycardic activities of Ivabradine.
IvacaftorThe serum concentration of Clonidine can be increased when it is combined with Ivacaftor.
IvosidenibThe metabolism of Clonidine can be increased when combined with Ivosidenib.
KetamineThe risk or severity of sedation can be increased when Clonidine is combined with Ketamine.
KetazolamThe risk or severity of sedation can be increased when Clonidine is combined with Ketazolam.
KetoconazoleThe metabolism of Clonidine can be decreased when combined with Ketoconazole.
KetoprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Ketoprofen.
KetorolacThe therapeutic efficacy of Clonidine can be decreased when used in combination with Ketorolac.
LabetalolThe risk or severity of hypotension can be increased when Clonidine is combined with Labetalol.
LacidipineClonidine may increase the hypotensive activities of Lacidipine.
LacosamideThe risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Clonidine is combined with Lacosamide.
LamotrigineThe risk or severity of sedation can be increased when Clonidine is combined with Lamotrigine.
LanreotideThe metabolism of Clonidine can be decreased when combined with Lanreotide.
LansoprazoleThe metabolism of Clonidine can be decreased when combined with Lansoprazole.
LapatinibThe metabolism of Clonidine can be decreased when combined with Lapatinib.
LasmiditanThe risk or severity of sedation can be increased when Clonidine is combined with Lasmiditan.
LefamulinThe serum concentration of Clonidine can be increased when it is combined with Lefamulin.
LeflunomideThe serum concentration of Clonidine can be decreased when it is combined with Leflunomide.
LemborexantThe risk or severity of sedation can be increased when Clonidine is combined with Lemborexant.
LenacapavirThe metabolism of Clonidine can be decreased when combined with Lenacapavir.
LeniolisibThe metabolism of Clonidine can be decreased when combined with Leniolisib.
LercanidipineThe risk or severity of hypotension can be increased when Clonidine is combined with Lercanidipine.
LesinuradThe metabolism of Clonidine can be increased when combined with Lesinurad.
LetermovirThe serum concentration of Clonidine can be increased when it is combined with Letermovir.
LevacetylmethadolThe risk or severity of sedation can be increased when Clonidine is combined with Levacetylmethadol.
LevamlodipineThe risk or severity of hypotension can be increased when Clonidine is combined with Levamlodipine.
LevetiracetamThe risk or severity of sedation can be increased when Clonidine is combined with Levetiracetam.
LevobetaxololThe metabolism of Clonidine can be decreased when combined with Levobetaxolol.
LevobupivacaineThe risk or severity of sedation can be increased when Clonidine is combined with Levobupivacaine.
LevocabastineThe risk or severity of sedation can be increased when Clonidine is combined with Levocabastine.
LevocetirizineThe risk or severity of sedation can be increased when Clonidine is combined with Levocetirizine.
LevodopaThe risk or severity of sedation can be increased when Clonidine is combined with Levodopa.
LevoketoconazoleThe metabolism of Clonidine can be decreased when combined with Levoketoconazole.
LevomentholClonidine may increase the bradycardic activities of Levomenthol.
LevomilnacipranLevomilnacipran may increase the tachycardic activities of Clonidine.
LevonordefrinLevonordefrin may decrease the antihypertensive activities of Clonidine.
LevonorgestrelThe risk or severity of sedation can be increased when Levonorgestrel is combined with Clonidine.
LevorphanolThe risk or severity of sedation can be increased when Clonidine is combined with Levorphanol.
LevosalbutamolLevosalbutamol may decrease the antihypertensive activities of Clonidine.
LevosimendanThe risk or severity of adverse effects can be increased when Clonidine is combined with Levosimendan.
LidocaineThe risk or severity of sedation can be increased when Clonidine is combined with Lidocaine.
LidoflazineClonidine may increase the atrioventricular blocking (AV block) activities of Lidoflazine.
LinagliptinThe metabolism of Clonidine can be decreased when combined with Linagliptin.
LinezolidLinezolid may increase the hypertensive activities of Clonidine.
LisdexamfetamineLisdexamfetamine may decrease the antihypertensive activities of Clonidine.
LisinoprilThe risk or severity of hypotension can be increased when Clonidine is combined with Lisinopril.
LisurideThe risk or severity of sedation can be increased when Clonidine is combined with Lisuride.
Lithium carbonateThe risk or severity of sedation can be increased when Clonidine is combined with Lithium carbonate.
LofexidineThe risk or severity of sedation can be increased when Clonidine is combined with Lofexidine.
LomefloxacinThe metabolism of Lomefloxacin can be decreased when combined with Clonidine.
LomitapideThe metabolism of Clonidine can be decreased when combined with Lomitapide.
LonafarnibThe metabolism of Clonidine can be decreased when combined with Lonafarnib.
LonapegsomatropinThe metabolism of Clonidine can be increased when combined with Lonapegsomatropin.
LoperamideClonidine may increase the bradycardic activities of Loperamide.
LopinavirThe metabolism of Clonidine can be decreased when combined with Lopinavir.
LorazepamThe risk or severity of sedation can be increased when Clonidine is combined with Lorazepam.
LorcaserinThe risk or severity of sedation can be increased when Clonidine is combined with Lorcaserin.
LorlatinibThe metabolism of Clonidine can be increased when combined with Lorlatinib.
LormetazepamThe risk or severity of sedation can be increased when Clonidine is combined with Lormetazepam.
LornoxicamThe therapeutic efficacy of Clonidine can be decreased when used in combination with Lornoxicam.
LorpiprazoleThe metabolism of Clonidine can be decreased when combined with Lorpiprazole.
LosartanThe risk or severity of hypotension can be increased when Clonidine is combined with Losartan.
LovastatinThe metabolism of Clonidine can be decreased when combined with Lovastatin.
LoxapineThe risk or severity of sedation can be increased when Clonidine is combined with Loxapine.
LoxoprofenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Loxoprofen.
LucinactantClonidine may increase the bradycardic activities of Lucinactant.
LumacaftorThe serum concentration of Clonidine can be decreased when it is combined with Lumacaftor.
LumateperoneThe risk or severity of sedation can be increased when Clonidine is combined with Lumateperone.
LumefantrineThe metabolism of Clonidine can be decreased when combined with Lumefantrine.
LumiracoxibThe therapeutic efficacy of Clonidine can be decreased when used in combination with Lumiracoxib.
LurasidoneThe risk or severity of sedation can be increased when Clonidine is combined with Lurasidone.
LynestrenolThe risk or severity of sedation can be increased when Lynestrenol is combined with Clonidine.
MacimorelinThe therapeutic efficacy of Macimorelin can be decreased when used in combination with Clonidine.
MacitentanThe risk or severity of hypotension can be increased when Clonidine is combined with Macitentan.
Magnesium sulfateThe risk or severity of sedation can be increased when Clonidine is combined with Magnesium sulfate.
ManidipineThe risk or severity of hypotension can be increased when Clonidine is combined with Manidipine.
MannitolThe risk or severity of adverse effects can be increased when Clonidine is combined with Mannitol.
MaprotilineThe risk or severity of sedation can be increased when Clonidine is combined with Maprotiline.
MavacamtenThe serum concentration of Clonidine can be decreased when it is combined with Mavacamten.
MazindolThe risk or severity of sedation can be increased when Clonidine is combined with Mazindol.
MebeverineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Mebeverine.
MebutamateThe risk or severity of sedation can be increased when Clonidine is combined with Mebutamate.
MecamylamineThe risk or severity of hypotension can be increased when Clonidine is combined with Mecamylamine.
MeclizineThe risk or severity of sedation can be increased when Clonidine is combined with Meclizine.
Meclofenamic acidThe therapeutic efficacy of Clonidine can be decreased when used in combination with Meclofenamic acid.
MedifoxamineThe risk or severity of sedation can be increased when Clonidine is combined with Medifoxamine.
Medroxyprogesterone acetateThe risk or severity of sedation can be increased when Medroxyprogesterone acetate is combined with Clonidine.
Mefenamic acidThe therapeutic efficacy of Clonidine can be decreased when used in combination with Mefenamic acid.
Megestrol acetateThe risk or severity of sedation can be increased when Megestrol acetate is combined with Clonidine.
MelatoninThe risk or severity of sedation can be increased when Clonidine is combined with Melatonin.
MeloxicamThe therapeutic efficacy of Clonidine can be decreased when used in combination with Meloxicam.
Menthyl salicylateThe therapeutic efficacy of Clonidine can be decreased when used in combination with Menthyl salicylate.
MepenzolateThe risk or severity of Tachycardia can be increased when Clonidine is combined with Mepenzolate.
MeperidineThe risk or severity of sedation can be increased when Clonidine is combined with Meperidine.
MephentermineMephentermine may decrease the antihypertensive activities of Clonidine.
MephenytoinThe risk or severity of sedation can be increased when Clonidine is combined with Mephenytoin.
MepivacaineThe risk or severity of sedation can be increased when Clonidine is combined with Mepivacaine.
MeprednisoneThe metabolism of Clonidine can be increased when combined with Meprednisone.
MeprobamateThe risk or severity of sedation can be increased when Clonidine is combined with Meprobamate.
MepyramineThe risk or severity of sedation can be increased when Clonidine is combined with Mepyramine.
MesalazineMesalazine may decrease the antihypertensive activities of Clonidine.
MesoridazineThe risk or severity of sedation can be increased when Clonidine is combined with Mesoridazine.
MestranolThe risk or severity of sedation can be increased when Mestranol is combined with Clonidine.
MetamfetamineThe metabolism of Clonidine can be decreased when combined with Metamfetamine.
MetamizoleMetamizole may decrease the antihypertensive activities of Clonidine.
MetaraminolMetaraminol may decrease the antihypertensive activities of Clonidine.
MetaxaloneThe risk or severity of sedation can be increased when Clonidine is combined with Metaxalone.
MetergolineThe risk or severity of sedation can be increased when Clonidine is combined with Metergoline.
MethadoneThe risk or severity of adverse effects can be increased when Methadone is combined with Clonidine.
MethanthelineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Methantheline.
MethazolamideThe risk or severity of adverse effects can be increased when Clonidine is combined with Methazolamide.
MethimazoleThe metabolism of Clonidine can be decreased when combined with Methimazole.
MethocarbamolThe risk or severity of sedation can be increased when Clonidine is combined with Methocarbamol.
MethohexitalThe risk or severity of sedation can be increased when Clonidine is combined with Methohexital.
MethotrimeprazineThe risk or severity of sedation can be increased when Clonidine is combined with Methotrimeprazine.
MethoxamineMethoxamine may decrease the antihypertensive activities of Clonidine.
MethoxsalenThe metabolism of Clonidine can be decreased when combined with Methoxsalen.
MethoxyfluraneThe risk or severity of sedation can be increased when Clonidine is combined with Methoxyflurane.
MethoxyphenamineMethoxyphenamine may decrease the antihypertensive activities of Clonidine.
MethscopolamineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Methscopolamine.
Methscopolamine bromideThe risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Clonidine.
MethsuximideThe risk or severity of sedation can be increased when Clonidine is combined with Methsuximide.
MethyldopaThe risk or severity of hypotension can be increased when Clonidine is combined with Methyldopa.
Methylene blueThe risk or severity of sedation can be increased when Clonidine is combined with Methylene blue.
MethylergometrineThe serum concentration of Clonidine can be increased when it is combined with Methylergometrine.
MethylphenidateThe risk or severity of adverse effects can be increased when Methylphenidate is combined with Clonidine.
MethylphenobarbitalThe risk or severity of sedation can be increased when Clonidine is combined with Methylphenobarbital.
MethylprednisoloneThe metabolism of Clonidine can be increased when combined with Methylprednisolone.
MethylprednisoneThe metabolism of Clonidine can be decreased when combined with Methylprednisone.
MethyprylonThe risk or severity of sedation can be increased when Clonidine is combined with Methyprylon.
MethysergideThe risk or severity of sedation can be increased when Clonidine is combined with Methysergide.
MetipranololClonidine may increase the hypotensive activities of Metipranolol.
MetixeneThe risk or severity of Tachycardia can be increased when Metixene is combined with Clonidine.
MetoclopramideThe risk or severity of sedation can be increased when Metoclopramide is combined with Clonidine.
MetocurineThe risk or severity of sedation can be increased when Clonidine is combined with Metocurine.
Metocurine iodideThe risk or severity of sedation can be increased when Clonidine is combined with Metocurine iodide.
MetolazoneThe risk or severity of hypotension can be increased when Clonidine is combined with Metolazone.
MetoprololThe risk or severity of hypotension can be increased when Clonidine is combined with Metoprolol.
MetreleptinThe metabolism of Clonidine can be increased when combined with Metreleptin.
MetronidazoleThe serum concentration of Clonidine can be increased when it is combined with Metronidazole.
MetyraponeThe metabolism of Clonidine can be increased when combined with Metyrapone.
MetyrosineThe risk or severity of hypotension can be increased when Clonidine is combined with Metyrosine.
MexiletineThe metabolism of Clonidine can be decreased when combined with Mexiletine.
MianserinThe risk or severity of sedation can be increased when Clonidine is combined with Mianserin.
MiconazoleThe metabolism of Clonidine can be decreased when combined with Miconazole.
MidazolamThe risk or severity of sedation can be increased when Clonidine is combined with Midazolam.
MidodrineMidodrine may decrease the antihypertensive activities of Clonidine.
MidostaurinThe metabolism of Clonidine can be decreased when combined with Midostaurin.
MifepristoneThe risk or severity of sedation can be increased when Mifepristone is combined with Clonidine.
MilnacipranThe risk or severity of sedation can be increased when Clonidine is combined with Milnacipran.
MinaprineThe risk or severity of sedation can be increased when Clonidine is combined with Minaprine.
MinocyclineMinocycline may increase the central nervous system depressant (CNS depressant) activities of Clonidine.
MinoxidilThe risk or severity of hypotension can be increased when Clonidine is combined with Minoxidil.
MiocamycinThe serum concentration of Clonidine can be increased when it is combined with Miocamycin.
MirabegronThe serum concentration of Clonidine can be increased when it is combined with Mirabegron.
MirtazapineThe risk or severity of sedation can be increased when Clonidine is combined with Mirtazapine.
MitapivatThe metabolism of Clonidine can be increased when combined with Mitapivat.
MitotaneThe metabolism of Clonidine can be increased when combined with Mitotane.
MivacuriumThe risk or severity of sedation can be increased when Clonidine is combined with Mivacurium.
MobocertinibThe serum concentration of Clonidine can be decreased when it is combined with Mobocertinib.
MoclobemideThe risk or severity of sedation can be increased when Clonidine is combined with Moclobemide.
ModafinilThe metabolism of Clonidine can be increased when combined with Modafinil.
MoexiprilThe risk or severity of hypotension can be increased when Clonidine is combined with Moexipril.
MolindoneThe risk or severity of sedation can be increased when Clonidine is combined with Molindone.
MolsidomineMolsidomine may increase the hypotensive activities of Clonidine.
Mometasone furoateThe metabolism of Clonidine can be increased when combined with Mometasone furoate.
MoricizineThe risk or severity of sedation can be increased when Clonidine is combined with Moricizine.
MorphineThe risk or severity of sedation can be increased when Clonidine is combined with Morphine.
MosunetuzumabThe metabolism of Clonidine can be decreased when combined with Mosunetuzumab.
MoxifloxacinThe metabolism of Clonidine can be decreased when combined with Moxifloxacin.
MoxisylyteMoxisylyte may decrease the antihypertensive activities of Clonidine.
MoxonidineThe risk or severity of hypotension can be increased when Clonidine is combined with Moxonidine.
MuzolimineThe risk or severity of hypotension can be increased when Clonidine is combined with Muzolimine.
Mycophenolate mofetilThe metabolism of Clonidine can be decreased when combined with Mycophenolate mofetil.
NabiloneThe risk or severity of sedation can be increased when Clonidine is combined with Nabilone.
NabumetoneThe therapeutic efficacy of Clonidine can be decreased when used in combination with Nabumetone.
NadololThe risk or severity of hypotension can be increased when Clonidine is combined with Nadolol.
NafcillinThe metabolism of Clonidine can be increased when combined with Nafcillin.
NalbuphineThe risk or severity of sedation can be increased when Clonidine is combined with Nalbuphine.
Nalidixic acidThe metabolism of Clonidine can be decreased when combined with Nalidixic acid.
NaloxegolThe risk or severity of hypotension can be increased when Naloxegol is combined with Clonidine.
NaltrexoneThe risk or severity of hypotension can be increased when Naltrexone is combined with Clonidine.
NaphazolineNaphazoline may decrease the antihypertensive activities of Clonidine.
NaproxenThe therapeutic efficacy of Clonidine can be decreased when used in combination with Naproxen.
NaratriptanThe risk or severity of sedation can be increased when Clonidine is combined with Naratriptan.
NateglinideThe metabolism of Clonidine can be decreased when combined with Nateglinide.
NaxitamabNaxitamab may decrease the antihypertensive activities of Clonidine.
NebivololThe risk or severity of hypotension can be increased when Clonidine is combined with Nebivolol.
NefazodoneThe risk or severity of sedation can be increased when Clonidine is combined with Nefazodone.
NelfinavirThe metabolism of Clonidine can be decreased when combined with Nelfinavir.
NesiritideThe risk or severity of adverse effects can be increased when Clonidine is combined with Nesiritide.
NetupitantThe metabolism of Clonidine can be decreased when combined with Netupitant.
NevirapineThe metabolism of Clonidine can be decreased when combined with Nevirapine.
NiacinThe serum concentration of Clonidine can be increased when it is combined with Niacin.
NialamideThe risk or severity of sedation can be increased when Clonidine is combined with Nialamide.
NicardipineThe risk or severity of hypotension can be increased when Clonidine is combined with Nicardipine.
NicergolineThe metabolism of Clonidine can be decreased when combined with Nicergoline.
NiclosamideThe metabolism of Clonidine can be decreased when combined with Niclosamide.
NicorandilThe risk or severity of hypotension can be increased when Clonidine is combined with Nicorandil.
NicotineThe risk or severity of Tachycardia can be increased when Nicotine is combined with Clonidine.
NifedipineClonidine may increase the atrioventricular blocking (AV block) activities of Nifedipine.
NilotinibThe metabolism of Clonidine can be decreased when combined with Nilotinib.
NilvadipineThe risk or severity of hypotension can be increased when Clonidine is combined with Nilvadipine.
NimesulideClonidine may increase the atrioventricular blocking (AV block) activities of Nimesulide.
NimodipineThe risk or severity of hypotension can be increased when Clonidine is combined with Nimodipine.
NintedanibThe metabolism of Clonidine can be decreased when combined with Nintedanib.
NirogacestatThe metabolism of Clonidine can be decreased when combined with Nirogacestat.
NisoldipineThe risk or severity of hypotension can be increased when Clonidine is combined with Nisoldipine.
NitrazepamThe risk or severity of sedation can be increased when Clonidine is combined with Nitrazepam.
NitrendipineThe risk or severity of hypotension can be increased when Clonidine is combined with Nitrendipine.
Nitric OxideThe risk or severity of adverse effects can be increased when Nitric Oxide is combined with Clonidine.
NitroglycerinThe risk or severity of hypotension can be increased when Clonidine is combined with Nitroglycerin.
NitroprussideThe risk or severity of hypotension can be increased when Clonidine is combined with Nitroprusside.
Nitrous acidThe risk or severity of adverse effects can be increased when Clonidine is combined with Nitrous acid.
Nitrous oxideThe risk or severity of sedation can be increased when Clonidine is combined with Nitrous oxide.
Nomegestrol acetateThe risk or severity of sedation can be increased when Nomegestrol acetate is combined with Clonidine.
NomifensineThe risk or severity of sedation can be increased when Clonidine is combined with Nomifensine.
NorepinephrineNorepinephrine may decrease the antihypertensive activities of Clonidine.
NorethisteroneThe risk or severity of sedation can be increased when Norethisterone is combined with Clonidine.
NorethynodrelThe risk or severity of sedation can be increased when Norethynodrel is combined with Clonidine.
NorfloxacinThe metabolism of Clonidine can be decreased when combined with Norfloxacin.
NorgestimateThe risk or severity of sedation can be increased when Norgestimate is combined with Clonidine.
NorgestrelThe risk or severity of sedation can be increased when Norgestrel is combined with Clonidine.
NormethadoneThe risk or severity of sedation can be increased when Clonidine is combined with Normethadone.
NortriptylineThe risk or severity of sedation can be increased when Clonidine is combined with Nortriptyline.
NoscapineThe serum concentration of Clonidine can be increased when it is combined with Noscapine.
NylidrinClonidine may increase the atrioventricular blocking (AV block) activities of Nylidrin.
Obeticholic acidThe risk or severity of adverse effects can be increased when Obeticholic acid is combined with Clonidine.
ObinutuzumabClonidine may increase the hypotensive activities of Obinutuzumab.
OctreotideThe serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Clonidine.
OlanzapineThe risk or severity of sedation can be increased when Clonidine is combined with Olanzapine.
OlaparibThe metabolism of Clonidine can be decreased when combined with Olaparib.
OliceridineThe risk or severity of sedation can be increased when Clonidine is combined with Oliceridine.
OlmesartanThe risk or severity of hypotension can be increased when Clonidine is combined with Olmesartan.
OlodaterolOlodaterol may decrease the antihypertensive activities of Clonidine.
OlutasidenibThe metabolism of Clonidine can be increased when combined with Olutasidenib.
OmaveloxoloneThe serum concentration of Clonidine can be decreased when it is combined with Omaveloxolone.
OndansetronThe risk or severity of sedation can be increased when Clonidine is combined with Ondansetron.
OpicaponeThe risk or severity of adverse effects can be increased when Clonidine is combined with Opicapone.
OpiumThe risk or severity of sedation can be increased when Clonidine is combined with Opium.
OrciprenalineOrciprenaline may decrease the antihypertensive activities of Clonidine.
OritavancinThe metabolism of Clonidine can be increased when combined with Oritavancin.
OrphenadrineThe risk or severity of sedation can be increased when Clonidine is combined with Orphenadrine.
OsilodrostatThe serum concentration of Clonidine can be increased when it is combined with Osilodrostat.
OsimertinibThe serum concentration of Clonidine can be decreased when it is combined with Osimertinib.
OspemifeneThe metabolism of Clonidine can be decreased when combined with Ospemifene.
OuabainClonidine may increase the atrioventricular blocking (AV block) activities of Ouabain.
OxamniquineThe metabolism of Clonidine can be decreased when combined with Oxamniquine.
OxaprozinThe therapeutic efficacy of Clonidine can be decreased when used in combination with Oxaprozin.
OxazepamThe risk or severity of sedation can be increased when Clonidine is combined with Oxazepam.
OxcarbazepineThe risk or severity of sedation can be increased when Clonidine is combined with Oxcarbazepine.
OxitriptanThe risk or severity of sedation can be increased when Clonidine is combined with Oxitriptan.
OxprenololThe risk or severity of sedation can be increased when Clonidine is combined with Oxprenolol.
OxtriphyllineThe metabolism of Oxtriphylline can be decreased when combined with Clonidine.
OxybuprocaineThe risk or severity of sedation can be increased when Clonidine is combined with Oxybuprocaine.
OxybutyninThe serum concentration of Clonidine can be increased when it is combined with Oxybutynin.
OxycodoneThe risk or severity of sedation can be increased when Clonidine is combined with Oxycodone.
OxymetazolineThe therapeutic efficacy of Clonidine can be decreased when used in combination with Oxymetazoline.
OxymorphoneThe risk or severity of sedation can be increased when Clonidine is combined with Oxymorphone.
OxyphenbutazoneThe therapeutic efficacy of Clonidine can be decreased when used in combination with Oxyphenbutazone.
OxyphencyclimineThe risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Clonidine.
OxyphenoniumThe risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Clonidine.
PaclitaxelThe metabolism of Clonidine can be increased when combined with Paclitaxel.
PacritinibThe serum concentration of Clonidine can be increased when it is combined with Pacritinib.
PalbociclibThe metabolism of Clonidine can be decreased when combined with Palbociclib.
PaliperidoneThe risk or severity of sedation can be increased when Clonidine is combined with Paliperidone.
PalonosetronThe risk or severity of sedation can be increased when Clonidine is combined with Palonosetron.
PalovaroteneThe metabolism of Clonidine can be increased when combined with Palovarotene.
PancuroniumThe risk or severity of sedation can be increased when Clonidine is combined with Pancuronium.
PanobinostatThe metabolism of Clonidine can be decreased when combined with Panobinostat.
PapaverineThe risk or severity of adverse effects can be increased when Clonidine is combined with Papaverine.
ParaldehydeThe risk or severity of sedation can be increased when Clonidine is combined with Paraldehyde.
ParamethadioneThe risk or severity of sedation can be increased when Clonidine is combined with Paramethadione.
ParecoxibThe therapeutic efficacy of Clonidine can be decreased when used in combination with Parecoxib.
PargylineThe risk or severity of sedation can be increased when Clonidine is combined with Pargyline.
ParitaprevirThe metabolism of Clonidine can be decreased when combined with Paritaprevir.
ParoxetineThe risk or severity of sedation can be increased when Clonidine is combined with Paroxetine.
PasireotideThe metabolism of Clonidine can be decreased when combined with Pasireotide.
PazopanibThe metabolism of Clonidine can be decreased when combined with Pazopanib.
PefloxacinThe metabolism of Clonidine can be decreased when combined with Pefloxacin.
Peginterferon alfa-2aThe metabolism of Clonidine can be decreased when combined with Peginterferon alfa-2a.
Peginterferon alfa-2bThe serum concentration of Clonidine can be increased when it is combined with Peginterferon alfa-2b.
PemetrexedThe metabolism of Pemetrexed can be decreased when combined with Clonidine.
PenbutololThe risk or severity of sedation can be increased when Clonidine is combined with Penbutolol.
PenciclovirThe metabolism of Clonidine can be decreased when combined with Penciclovir.
PentamidineThe metabolism of Clonidine can be decreased when combined with Pentamidine.
PentazocineThe risk or severity of sedation can be increased when Clonidine is combined with Pentazocine.
PentobarbitalThe risk or severity of sedation can be increased when Clonidine is combined with Pentobarbital.
PentoliniumThe risk or severity of hypotension can be increased when Clonidine is combined with Pentolinium.
PentoxifyllinePentoxifylline may increase the hypotensive activities of Clonidine.
PerampanelThe risk or severity of sedation can be increased when Clonidine is combined with Perampanel.
PerazineThe risk or severity of sedation can be increased when Clonidine is combined with Perazine.
PergolideThe risk or severity of sedation can be increased when Clonidine is combined with Pergolide.
PerhexilineClonidine may increase the atrioventricular blocking (AV block) activities of Perhexiline.
PericiazineThe risk or severity of sedation can be increased when Clonidine is combined with Periciazine.
PerindoprilThe risk or severity of hypotension can be increased when Clonidine is combined with Perindopril.
PerphenazineThe risk or severity of sedation can be increased when Clonidine is combined with Perphenazine.
PhenacemideThe risk or severity of sedation can be increased when Clonidine is combined with Phenacemide.
PhendimetrazinePhendimetrazine may decrease the antihypertensive activities of Clonidine.
PhenelzineThe risk or severity of sedation can be increased when Clonidine is combined with Phenelzine.
PhenforminThe metabolism of Clonidine can be decreased when combined with Phenformin.
PhenmetrazinePhenmetrazine may decrease the antihypertensive activities of Clonidine.
PhenobarbitalThe risk or severity of sedation can be increased when Clonidine is combined with Phenobarbital.
PhenoxybenzamineThe risk or severity of hypotension can be increased when Clonidine is combined with Phenoxybenzamine.
PhensuximideThe risk or severity of sedation can be increased when Clonidine is combined with Phensuximide.
PhenterminePhentermine may decrease the antihypertensive activities of Clonidine.
PhentolamineThe risk or severity of hypotension can be increased when Clonidine is combined with Phentolamine.
PhenylbutazoneThe metabolism of Clonidine can be increased when combined with Phenylbutazone.
Phenylbutyric acidThe metabolism of Clonidine can be decreased when combined with Phenylbutyric acid.
PhenylephrineThe metabolism of Clonidine can be increased when combined with Phenylephrine.
PhenylpropanolaminePhenylpropanolamine may decrease the antihypertensive activities of Clonidine.
PhenytoinThe risk or severity of sedation can be increased when Clonidine is combined with Phenytoin.
PimavanserinThe metabolism of Clonidine can be decreased when combined with Pimavanserin.
PimozideThe risk or severity of sedation can be increased when Clonidine is combined with Pimozide.
PinacidilThe risk or severity of hypotension can be increased when Clonidine is combined with Pinacidil.
PinaveriumClonidine may increase the atrioventricular blocking (AV block) activities of Pinaverium.
PindololThe risk or severity of sedation can be increased when Clonidine is combined with Pindolol.
PipecuroniumThe risk or severity of sedation can be increased when Clonidine is combined with Pipecuronium.
PiperaquineThe metabolism of Clonidine can be decreased when combined with Piperaquine.
PiperazineThe metabolism of Clonidine can be decreased when combined with Piperazine.
PipotiazineThe risk or severity of sedation can be increased when Clonidine is combined with Pipotiazine.
PirbuterolPirbuterol may decrease the antihypertensive activities of Clonidine.
PirenzepineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Pirenzepine.
PirfenidoneThe metabolism of Clonidine can be decreased when combined with Pirfenidone.
PiritramideThe risk or severity of sedation can be increased when Clonidine is combined with Piritramide.
PiroxicamThe therapeutic efficacy of Clonidine can be decreased when used in combination with Piroxicam.
PirtobrutinibThe metabolism of Clonidine can be decreased when combined with Pirtobrutinib.
PitolisantThe serum concentration of Clonidine can be decreased when it is combined with Pitolisant.
PizotifenThe risk or severity of sedation can be increased when Clonidine is combined with Pizotifen.
PolythiazideThe risk or severity of hypotension can be increased when Clonidine is combined with Polythiazide.
PomalidomideThe risk or severity of sedation can be increased when Clonidine is combined with Pomalidomide.
PonatinibThe metabolism of Ponatinib can be decreased when combined with Clonidine.
PonesimodThe risk or severity of bradycardia can be increased when Ponesimod is combined with Clonidine.
Poractant alfaClonidine may increase the bradycardic activities of Poractant alfa.
PosaconazoleThe metabolism of Clonidine can be decreased when combined with Posaconazole.
PractololThe risk or severity of hypotension can be increased when Clonidine is combined with Practolol.
PralsetinibThe metabolism of Clonidine can be increased when combined with Pralsetinib.
PramipexoleClonidine may increase the sedative activities of Pramipexole.
PramocaineThe risk or severity of sedation can be increased when Clonidine is combined with Pramocaine.
PrazepamThe risk or severity of sedation can be increased when Clonidine is combined with Prazepam.
PraziquantelThe metabolism of Clonidine can be decreased when combined with Praziquantel.
PrazosinThe risk or severity of hypotension can be increased when Prazosin is combined with Clonidine.
PrednisoloneThe metabolism of Clonidine can be increased when combined with Prednisolone.
Prednisolone acetateThe metabolism of Clonidine can be increased when combined with Prednisolone acetate.
Prednisolone phosphateThe metabolism of Clonidine can be increased when combined with Prednisolone phosphate.
Prednisone acetateThe metabolism of Clonidine can be increased when combined with Prednisone acetate.
PregabalinThe risk or severity of sedation can be increased when Clonidine is combined with Pregabalin.
PrenylamineClonidine may increase the atrioventricular blocking (AV block) activities of Prenylamine.
PretomanidThe metabolism of Clonidine can be decreased when combined with Pretomanid.
PrilocaineThe risk or severity of sedation can be increased when Clonidine is combined with Prilocaine.
PrimaquineThe metabolism of Clonidine can be decreased when combined with Primaquine.
PrimidoneThe risk or severity of sedation can be increased when Clonidine is combined with Primidone.
ProbenecidThe metabolism of Clonidine can be increased when combined with Probenecid.
ProcainamideThe metabolism of Procainamide can be decreased when combined with Clonidine.
ProcaineThe risk or severity of sedation can be increased when Clonidine is combined with Procaine.
ProcarbazineThe risk or severity of sedation can be increased when Clonidine is combined with Procarbazine.
ProcaterolProcaterol may decrease the antihypertensive activities of Clonidine.
ProchlorperazineThe risk or severity of sedation can be increased when Clonidine is combined with Prochlorperazine.
ProcyclidineThe risk or severity of Tachycardia can be increased when Procyclidine is combined with Clonidine.
ProfenamineThe therapeutic efficacy of Clonidine can be decreased when used in combination with Profenamine.
ProgesteroneThe metabolism of Clonidine can be decreased when combined with Progesterone.
ProguanilThe metabolism of Clonidine can be decreased when combined with Proguanil.
PromazineThe risk or severity of sedation can be increased when Clonidine is combined with Promazine.
PromethazineThe risk or severity of sedation can be increased when Clonidine is combined with Promethazine.
PropafenoneThe metabolism of Clonidine can be decreased when combined with Propafenone.
PropanthelineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Propantheline.
PropiomazineThe risk or severity of sedation can be increased when Clonidine is combined with Propiomazine.
PropiverineThe therapeutic efficacy of Clonidine can be decreased when used in combination with Propiverine.
PropofolThe risk or severity of sedation can be increased when Clonidine is combined with Propofol.
PropranololThe risk or severity of hypotension can be increased when Clonidine is combined with Propranolol.
ProtokylolThe risk or severity of Tachycardia can be increased when Clonidine is combined with Protokylol.
ProtriptylineThe risk or severity of sedation can be increased when Clonidine is combined with Protriptyline.
ProxibarbalThe risk or severity of sedation can be increased when Clonidine is combined with Proxibarbal.
PseudoephedrinePseudoephedrine may decrease the antihypertensive activities of Clonidine.
PyrantelThe risk or severity of sedation can be increased when Clonidine is combined with Pyrantel.
QuazepamThe risk or severity of sedation can be increased when Clonidine is combined with Quazepam.
QuetiapineThe risk or severity of sedation can be increased when Clonidine is combined with Quetiapine.
QuinaprilThe risk or severity of hypotension can be increased when Clonidine is combined with Quinapril.
QuinidineThe metabolism of Clonidine can be decreased when combined with Quinidine.
QuinineThe risk or severity of sedation can be increased when Clonidine is combined with Quinine.
QuinupramineThe risk or severity of sedation can be increased when Clonidine is combined with Quinupramine.
QuinupristinThe metabolism of Clonidine can be decreased when combined with Quinupristin.
QuizartinibThe metabolism of Clonidine can be decreased when combined with Quizartinib.
RacepinephrineRacepinephrine may decrease the antihypertensive activities of Clonidine.
RaloxifeneThe serum concentration of Clonidine can be increased when it is combined with Raloxifene.
RamelteonThe risk or severity of sedation can be increased when Clonidine is combined with Ramelteon.
RamiprilThe risk or severity of hypotension can be increased when Clonidine is combined with Ramipril.
RanitidineThe metabolism of Clonidine can be decreased when combined with Ranitidine.
RanolazineThe serum concentration of Clonidine can be increased when it is combined with Ranolazine.
RapacuroniumThe risk or severity of sedation can be increased when Clonidine is combined with Rapacuronium.
RasagilineThe risk or severity of sedation can be increased when Clonidine is combined with Rasagiline.
ReboxetineThe risk or severity of sedation can be increased when Clonidine is combined with Reboxetine.
RegorafenibClonidine may increase the bradycardic activities of Regorafenib.
RelugolixThe metabolism of Clonidine can be decreased when combined with Relugolix.
RemdesivirThe metabolism of Clonidine can be decreased when combined with Remdesivir.
RemifentanilThe risk or severity of sedation can be increased when Clonidine is combined with Remifentanil.
RemimazolamThe risk or severity of sedation can be increased when Clonidine is combined with Remimazolam.
RemoxiprideThe risk or severity of sedation can be increased when Clonidine is combined with Remoxipride.
RepotrectinibThe serum concentration of Clonidine can be decreased when it is combined with Repotrectinib.
RescinnamineThe risk or severity of hypotension can be increased when Clonidine is combined with Rescinnamine.
ReserpineThe risk or severity of sedation can be increased when Clonidine is combined with Reserpine.
RevefenacinThe metabolism of Clonidine can be decreased when combined with Revefenacin.
RibociclibThe metabolism of Clonidine can be decreased when combined with Ribociclib.
RifabutinThe metabolism of Clonidine can be increased when combined with Rifabutin.
RifampicinThe metabolism of Clonidine can be increased when combined with Rifampicin.
RifamycinThe metabolism of Clonidine can be increased when combined with Rifamycin.
RifapentineThe metabolism of Clonidine can be increased when combined with Rifapentine.
RilmenidineThe risk or severity of hypotension can be increased when Clonidine is combined with Rilmenidine.
RilonaceptThe metabolism of Clonidine can be increased when combined with Rilonacept.
RilpivirineThe metabolism of Clonidine can be decreased when combined with Rilpivirine.
RiluzoleThe risk or severity of sedation can be increased when Clonidine is combined with Riluzole.
RimonabantThe risk or severity of adverse effects can be increased when Rimonabant is combined with Clonidine.
RiociguatThe risk or severity of hypotension can be increased when Clonidine is combined with Riociguat.
RisperidoneThe risk or severity of sedation can be increased when Clonidine is combined with Risperidone.
RitlecitinibThe serum concentration of Clonidine can be increased when it is combined with Ritlecitinib.
RitodrineRitodrine may decrease the antihypertensive activities of Clonidine.
RitonavirThe serum concentration of Clonidine can be increased when it is combined with Ritonavir.
RituximabClonidine may increase the hypotensive activities of Rituximab.
RivaroxabanThe metabolism of Clonidine can be decreased when combined with Rivaroxaban.
RivastigmineClonidine may increase the bradycardic activities of Rivastigmine.
RizatriptanRizatriptan may decrease the antihypertensive activities of Clonidine.
RocuroniumThe risk or severity of sedation can be increased when Clonidine is combined with Rocuronium.
RofecoxibThe metabolism of Clonidine can be increased when combined with Rofecoxib.
RoflumilastThe metabolism of Clonidine can be decreased when combined with Roflumilast.
RolapitantThe metabolism of Clonidine can be decreased when combined with Rolapitant.
RomidepsinThe metabolism of Clonidine can be decreased when combined with Romidepsin.
Ropeginterferon alfa-2bThe risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Clonidine.
RopiniroleClonidine may increase the sedative activities of Ropinirole.
RopivacaineThe risk or severity of sedation can be increased when Clonidine is combined with Ropivacaine.
RosoxacinThe metabolism of Clonidine can be decreased when combined with Rosoxacin.
RosuvastatinThe metabolism of Clonidine can be decreased when combined with Rosuvastatin.
RotigotineThe risk or severity of sedation can be increased when Clonidine is combined with Rotigotine.
RoxithromycinThe metabolism of Clonidine can be decreased when combined with Roxithromycin.
RucaparibThe metabolism of Clonidine can be decreased when combined with Rucaparib.
RufinamideThe risk or severity of sedation can be increased when Clonidine is combined with Rufinamide.
RupatadineThe metabolism of Clonidine can be decreased when combined with Rupatadine.
RuxolitinibRuxolitinib may increase the bradycardic activities of Clonidine.
SacubitrilThe risk or severity of adverse effects can be increased when Clonidine is combined with Sacubitril.
SafinamideThe risk or severity of sedation can be increased when Clonidine is combined with Safinamide.
SalicylamideThe therapeutic efficacy of Clonidine can be decreased when used in combination with Salicylamide.
Salicylic acidThe therapeutic efficacy of Clonidine can be decreased when used in combination with Salicylic acid.
SalmeterolThe metabolism of Clonidine can be decreased when combined with Salmeterol.
SalsalateThe therapeutic efficacy of Clonidine can be decreased when used in combination with Salsalate.
SamidorphanThe risk or severity of sedation can be increased when Clonidine is combined with Samidorphan.
SaquinavirThe metabolism of Clonidine can be decreased when combined with Saquinavir.
SarilumabThe metabolism of Clonidine can be increased when combined with Sarilumab.
SatralizumabThe serum concentration of Clonidine can be decreased when it is combined with Satralizumab.
SaxagliptinThe metabolism of Clonidine can be decreased when combined with Saxagliptin.
ScopolamineThe risk or severity of sedation can be increased when Clonidine is combined with Scopolamine.
SecobarbitalThe risk or severity of sedation can be increased when Clonidine is combined with Secobarbital.
SecukinumabThe metabolism of Clonidine can be increased when combined with Secukinumab.
SelegilineThe risk or severity of sedation can be increased when Clonidine is combined with Selegiline.
SelexipagThe risk or severity of hypotension can be increased when Clonidine is combined with Selexipag.
SelpercatinibSelpercatinib may decrease the antihypertensive activities of Clonidine.
SelumetinibThe metabolism of Clonidine can be decreased when combined with Selumetinib.
SerdexmethylphenidateThe therapeutic efficacy of Clonidine can be decreased when used in combination with Serdexmethylphenidate.
SertindoleThe risk or severity of sedation can be increased when Clonidine is combined with Sertindole.
SertralineThe risk or severity of sedation can be increased when Clonidine is combined with Sertraline.
SevofluraneThe risk or severity of sedation can be increased when Clonidine is combined with Sevoflurane.
SibutramineThe risk or severity of sedation can be increased when Clonidine is combined with Sibutramine.
SildenafilThe metabolism of Clonidine can be decreased when combined with Sildenafil.
SilodosinThe risk or severity of orthostatic hypotension and dizziness can be increased when Clonidine is combined with Silodosin.
SiltuximabThe metabolism of Clonidine can be increased when combined with Siltuximab.
SimeprevirThe metabolism of Clonidine can be decreased when combined with Simeprevir.
SimvastatinThe metabolism of Clonidine can be decreased when combined with Simvastatin.
SiponimodThe metabolism of Clonidine can be decreased when combined with Siponimod.
SirolimusThe metabolism of Sirolimus can be decreased when combined with Clonidine.
SitaxentanThe risk or severity of hypotension can be increased when Clonidine is combined with Sitaxentan.
Sodium ferric gluconate complexThe risk or severity of hypotension can be increased when Sodium ferric gluconate complex is combined with Clonidine.
Sodium oxybateClonidine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
SolifenacinThe metabolism of Clonidine can be decreased when combined with Solifenacin.
SolriamfetolThe risk or severity of sedation can be increased when Clonidine is combined with Solriamfetol.
SomapacitanThe metabolism of Clonidine can be increased when combined with Somapacitan.
SomatostatinThe metabolism of Clonidine can be decreased when combined with Somatostatin.
SomatotropinThe metabolism of Clonidine can be increased when combined with Somatotropin.
SomatremThe metabolism of Clonidine can be increased when combined with Somatrem.
SomatrogonThe metabolism of Clonidine can be increased when combined with Somatrogon.
SorafenibThe metabolism of Clonidine can be decreased when combined with Sorafenib.
SotalolThe risk or severity of bradycardia can be increased when Clonidine is combined with Sotalol.
SotorasibThe serum concentration of Clonidine can be decreased when it is combined with Sotorasib.
SpiraprilThe risk or severity of hypotension can be increased when Clonidine is combined with Spirapril.
SpironolactoneThe risk or severity of hypotension can be increased when Clonidine is combined with Spironolactone.
St. John's WortThe risk or severity of sedation can be increased when Clonidine is combined with St. John's Wort.
StiripentolThe risk or severity of sedation can be increased when Clonidine is combined with Stiripentol.
StreptokinaseThe risk or severity of adverse effects can be increased when Streptokinase is combined with Clonidine.
SuccinylcholineThe risk or severity of sedation can be increased when Clonidine is combined with Succinylcholine.
SufentanilThe risk or severity of sedation can be increased when Clonidine is combined with Sufentanil.
SulfamethoxazoleThe serum concentration of Clonidine can be increased when it is combined with Sulfamethoxazole.
SulfaphenazoleThe metabolism of Clonidine can be decreased when combined with Sulfaphenazole.
SulfasalazineThe therapeutic efficacy of Clonidine can be decreased when used in combination with Sulfasalazine.
SulfinpyrazoneThe metabolism of Clonidine can be increased when combined with Sulfinpyrazone.
SulindacThe therapeutic efficacy of Clonidine can be decreased when used in combination with Sulindac.
SulpirideThe risk or severity of sedation can be increased when Clonidine is combined with Sulpiride.
SulthiameThe risk or severity of sedation can be increased when Clonidine is combined with Sulthiame.
SultoprideThe risk or severity of sedation can be increased when Clonidine is combined with Sultopride.
SumatriptanThe risk or severity of sedation can be increased when Clonidine is combined with Sumatriptan.
SunitinibThe metabolism of Sunitinib can be decreased when combined with Clonidine.
SuvorexantThe risk or severity of sedation can be increased when Clonidine is combined with Suvorexant.
TacrineThe metabolism of Clonidine can be decreased when combined with Tacrine.
TacrolimusThe metabolism of Clonidine can be decreased when combined with Tacrolimus.
TadalafilThe risk or severity of hypotension can be increased when Clonidine is combined with Tadalafil.
TafenoquineThe metabolism of Clonidine can be decreased when combined with Tafenoquine.
TalbutalThe risk or severity of sedation can be increased when Clonidine is combined with Talbutal.
TamoxifenThe metabolism of Clonidine can be increased when combined with Tamoxifen.
TamsulosinThe metabolism of Clonidine can be decreased when combined with Tamsulosin.
TapentadolThe risk or severity of sedation can be increased when Clonidine is combined with Tapentadol.
TasimelteonThe risk or severity of sedation can be increased when Clonidine is combined with Tasimelteon.
TazemetostatThe metabolism of Clonidine can be decreased when combined with Tazemetostat.
TecovirimatThe metabolism of Clonidine can be increased when combined with Tecovirimat.
TegafurThe metabolism of Tegafur can be decreased when combined with Clonidine.
TegaserodThe metabolism of Clonidine can be decreased when combined with Tegaserod.
TelaprevirThe metabolism of Clonidine can be decreased when combined with Telaprevir.
TelithromycinThe metabolism of Clonidine can be decreased when combined with Telithromycin.
TelmisartanThe risk or severity of hypotension can be increased when Clonidine is combined with Telmisartan.
Telotristat ethylThe serum concentration of Clonidine can be decreased when it is combined with Telotristat ethyl.
TemazepamThe risk or severity of sedation can be increased when Clonidine is combined with Temazepam.
TemsirolimusThe metabolism of Clonidine can be decreased when combined with Temsirolimus.
TeniposideThe serum concentration of Clonidine can be increased when it is combined with Teniposide.
Tenofovir alafenamideThe metabolism of Clonidine can be decreased when combined with Tenofovir alafenamide.
TenoxicamThe therapeutic efficacy of Clonidine can be decreased when used in combination with Tenoxicam.
TerazosinThe risk or severity of hypotension can be increased when Clonidine is combined with Terazosin.
TerbinafineThe metabolism of Clonidine can be decreased when combined with Terbinafine.
TerbutalineTerbutaline may decrease the antihypertensive activities of Clonidine.
TerfenadineThe metabolism of Clonidine can be decreased when combined with Terfenadine.
TeriflunomideThe serum concentration of Clonidine can be decreased when it is combined with Teriflunomide.
TestosteroneThe metabolism of Clonidine can be increased when combined with Testosterone.
Testosterone cypionateThe metabolism of Clonidine can be decreased when combined with Testosterone cypionate.
Testosterone enanthateThe metabolism of Clonidine can be decreased when combined with Testosterone enanthate.
Testosterone undecanoateTestosterone undecanoate may increase the hypertensive activities of Clonidine.
TetrabenazineThe metabolism of Clonidine can be decreased when combined with Tetrabenazine.
TetracaineThe risk or severity of sedation can be increased when Clonidine is combined with Tetracaine.
TetracyclineThe serum concentration of Clonidine can be increased when it is combined with Tetracycline.
TetryzolineTetryzoline may decrease the antihypertensive activities of Clonidine.
TezacaftorThe metabolism of Clonidine can be decreased when combined with Tezacaftor.
ThalidomideClonidine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
TheophyllineThe metabolism of Clonidine can be decreased when combined with Theophylline.
ThiabendazoleThe metabolism of Clonidine can be decreased when combined with Thiabendazole.
ThiamylalThe risk or severity of sedation can be increased when Clonidine is combined with Thiamylal.
ThiethylperazineThe risk or severity of sedation can be increased when Clonidine is combined with Thiethylperazine.
ThiopentalThe risk or severity of sedation can be increased when Clonidine is combined with Thiopental.
ThioridazineThe risk or severity of sedation can be increased when Clonidine is combined with Thioridazine.
ThiothixeneThe risk or severity of sedation can be increased when Clonidine is combined with Thiothixene.
ThonzylamineThe risk or severity of Tachycardia can be increased when Clonidine is combined with Thonzylamine.
TiagabineThe risk or severity of sedation can be increased when Clonidine is combined with Tiagabine.
Tiaprofenic acidThe therapeutic efficacy of Clonidine can be decreased when used in combination with Tiaprofenic acid.
TicagrelorThe metabolism of Clonidine can be decreased when combined with Ticagrelor.
TiclopidineThe metabolism of Clonidine can be decreased when combined with Ticlopidine.
TimololTimolol may increase the hypertensive activities of Clonidine.
TiotropiumThe metabolism of Clonidine can be decreased when combined with Tiotropium.
TipranavirThe metabolism of Clonidine can be decreased when combined with Tipranavir.
TizanidineThe risk or severity of adverse effects can be increased when Tizanidine is combined with Clonidine.
TocainideThe metabolism of Clonidine can be decreased when combined with Tocainide.
TocilizumabThe metabolism of Clonidine can be increased when combined with Tocilizumab.
TofacitinibClonidine may increase the bradycardic activities of Tofacitinib.
TolazolineThe risk or severity of hypotension can be increased when Clonidine is combined with Tolazoline.
TolcaponeThe risk or severity of sedation can be increased when Clonidine is combined with Tolcapone.
Tolfenamic acidThe therapeutic efficacy of Clonidine can be decreased when used in combination with Tolfenamic acid.
TolmetinThe therapeutic efficacy of Clonidine can be decreased when used in combination with Tolmetin.
TolterodineThe metabolism of Clonidine can be decreased when combined with Tolterodine.
TopiramateThe risk or severity of sedation can be increased when Clonidine is combined with Topiramate.
TorasemideThe risk or severity of hypotension can be increased when Clonidine is combined with Torasemide.
TovorafenibThe metabolism of Clonidine can be increased when combined with Tovorafenib.
TrabectedinThe metabolism of Trabectedin can be decreased when combined with Clonidine.
TramadolThe risk or severity of sedation can be increased when Clonidine is combined with Tramadol.
TrandolaprilThe risk or severity of hypotension can be increased when Clonidine is combined with Trandolapril.
TranylcypromineThe risk or severity of sedation can be increased when Clonidine is combined with Tranylcypromine.
Trastuzumab emtansineThe metabolism of Trastuzumab emtansine can be decreased when combined with Clonidine.
TrazodoneThe risk or severity of sedation can be increased when Clonidine is combined with Trazodone.
TreprostinilThe risk or severity of hypotension can be increased when Clonidine is combined with Treprostinil.
TretinoinThe risk or severity of elevated intracranial pressure can be increased when Clonidine is combined with Tretinoin.
TriamcinoloneThe metabolism of Clonidine can be increased when combined with Triamcinolone.
TriamtereneThe metabolism of Clonidine can be decreased when combined with Triamterene.
TriazolamThe risk or severity of sedation can be increased when Clonidine is combined with Triazolam.
TrichlormethiazideThe risk or severity of hypotension can be increased when Clonidine is combined with Trichlormethiazide.
TrichloroethyleneThe risk or severity of sedation can be increased when Clonidine is combined with Trichloroethylene.
TriclabendazoleThe serum concentration of Clonidine can be increased when it is combined with Triclabendazole.
TriclofosThe risk or severity of sedation can be increased when Clonidine is combined with Triclofos.
TrifluoperazineThe risk or severity of sedation can be increased when Clonidine is combined with Trifluoperazine.
TriflupromazineThe risk or severity of sedation can be increased when Clonidine is combined with Triflupromazine.
TrihexyphenidylThe risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Clonidine.
TrilaciclibThe metabolism of Clonidine can be increased when combined with Trilaciclib.
TrimebutineClonidine may increase the atrioventricular blocking (AV block) activities of Trimebutine.
TrimethadioneThe risk or severity of sedation can be increased when Clonidine is combined with Trimethadione.
TrimethaphanThe risk or severity of hypotension can be increased when Clonidine is combined with Trimethaphan.
TrimethobenzamideThe risk or severity of sedation can be increased when Clonidine is combined with Trimethobenzamide.
TrimipramineThe risk or severity of sedation can be increased when Clonidine is combined with Trimipramine.
TripelennamineThe metabolism of Clonidine can be decreased when combined with Tripelennamine.
TriprolidineThe risk or severity of sedation can be increased when Clonidine is combined with Triprolidine.
TrofinetideThe metabolism of Clonidine can be decreased when combined with Trofinetide.
TroglitazoneThe metabolism of Clonidine can be increased when combined with Troglitazone.
TroleandomycinThe metabolism of Clonidine can be decreased when combined with Troleandomycin.
TropisetronThe risk or severity of sedation can be increased when Clonidine is combined with Tropisetron.
TrospiumThe metabolism of Clonidine can be decreased when combined with Trospium.
TrovafloxacinThe metabolism of Clonidine can be decreased when combined with Trovafloxacin.
TryptophanThe risk or severity of sedation can be increased when Clonidine is combined with Tryptophan.
TubocurarineThe risk or severity of sedation can be increased when Clonidine is combined with Tubocurarine.
TucatinibThe metabolism of Tucatinib can be decreased when combined with Clonidine.
UdenafilThe metabolism of Clonidine can be decreased when combined with Udenafil.
UmeclidiniumThe metabolism of Clonidine can be decreased when combined with Umeclidinium.
UnoprostoneClonidine may increase the hypotensive activities of Unoprostone.
UrethaneThe risk or severity of sedation can be increased when Clonidine is combined with Urethane.
VadadustatThe serum concentration of Clonidine can be increased when it is combined with Vadadustat.
ValbenazineThe metabolism of Clonidine can be decreased when combined with Valbenazine.
ValdecoxibThe therapeutic efficacy of Clonidine can be decreased when used in combination with Valdecoxib.
Valproic acidThe risk or severity of sedation can be increased when Clonidine is combined with Valproic acid.
ValsartanThe risk or severity of hypotension can be increased when Clonidine is combined with Valsartan.
VardenafilThe metabolism of Clonidine can be decreased when combined with Vardenafil.
VecuroniumThe risk or severity of sedation can be increased when Clonidine is combined with Vecuronium.
VemurafenibThe serum concentration of Clonidine can be increased when it is combined with Vemurafenib.
VenetoclaxThe metabolism of Clonidine can be decreased when combined with Venetoclax.
VenlafaxineThe risk or severity of sedation can be increased when Clonidine is combined with Venlafaxine.
VerapamilVerapamil may increase the atrioventricular blocking (AV block) activities of Clonidine.
VericiguatThe risk or severity of adverse effects can be increased when Clonidine is combined with Vericiguat.
VernakalantThe metabolism of Clonidine can be decreased when combined with Vernakalant.
VigabatrinThe risk or severity of sedation can be increased when Clonidine is combined with Vigabatrin.
VilanterolVilanterol may decrease the antihypertensive activities of Clonidine.
VilazodoneThe risk or severity of sedation can be increased when Clonidine is combined with Vilazodone.
ViloxazineThe risk or severity of sedation can be increased when Clonidine is combined with Viloxazine.
VinblastineThe metabolism of Clonidine can be increased when combined with Vinblastine.
VincristineThe metabolism of Clonidine can be decreased when combined with Vincristine.
VinorelbineThe metabolism of Clonidine can be decreased when combined with Vinorelbine.
Vitamin EThe metabolism of Clonidine can be increased when combined with Vitamin E.
VonoprazanThe metabolism of Clonidine can be decreased when combined with Vonoprazan.
VorapaxarThe metabolism of Clonidine can be decreased when combined with Vorapaxar.
VoriconazoleThe metabolism of Clonidine can be decreased when combined with Voriconazole.
VortioxetineThe risk or severity of sedation can be increased when Clonidine is combined with Vortioxetine.
VoxelotorThe serum concentration of Clonidine can be increased when it is combined with Voxelotor.
VoxilaprevirThe metabolism of Voxilaprevir can be decreased when combined with Clonidine.
WarfarinThe metabolism of Clonidine can be increased when combined with Warfarin.
XamoterolXamoterol may decrease the antihypertensive activities of Clonidine.
XylometazolineClonidine may increase the atrioventricular blocking (AV block) activities of Xylometazoline.
YohimbineThe risk or severity of sedation can be increased when Clonidine is combined with Yohimbine.
ZafirlukastThe serum concentration of Clonidine can be increased when it is combined with Zafirlukast.
ZaleplonThe risk or severity of sedation can be increased when Clonidine is combined with Zaleplon.
ZiconotideThe risk or severity of sedation can be increased when Clonidine is combined with Ziconotide.
ZileutonThe metabolism of Clonidine can be decreased when combined with Zileuton.
ZimelidineThe risk or severity of sedation can be increased when Clonidine is combined with Zimelidine.
ZiprasidoneThe risk or severity of sedation can be increased when Clonidine is combined with Ziprasidone.
ZofenoprilThe risk or severity of hypotension can be increased when Clonidine is combined with Zofenopril.
ZolmitriptanThe risk or severity of sedation can be increased when Clonidine is combined with Zolmitriptan.
ZolpidemThe risk or severity of sedation can be increased when Clonidine is combined with Zolpidem.
ZonisamideThe risk or severity of sedation can be increased when Clonidine is combined with Zonisamide.
ZopicloneThe risk or severity of sedation can be increased when Clonidine is combined with Zopiclone.
ZotepineThe risk or severity of sedation can be increased when Clonidine is combined with Zotepine.
ZuclopenthixolThe risk or severity of sedation can be increased when Clonidine is combined with Zuclopenthixol.
ZuranoloneThe risk or severity of sedation can be increased when Clonidine is combined with Zuranolone.
Food Interactions
  • Avoid alcohol.
  • Take with or without food. The absorption is unaffected by food.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Clonidine hydrochlorideW76I6XXF064205-91-8ZNIFSRGNXRYGHF-UHFFFAOYSA-N
Product Images
International/Other Brands
Catapresan (Boehringer Ingelheim) / Catapressan (Boehringer Ingelheim) / Catarpres-TTS / Dixarit (Boehringer Ingelheim) / Isoglaucon (Agepha) / Run Rui (Bausch & Lomb) / Velaril (Roemmers) / Winpress (Winston)
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
CatapresTablet0.100 mg/1OralPhysicians Total Care, Inc.1974-09-032011-06-30US flag
CatapresTablet0.300 mg/1OralBoehringer Ingelheim Pharmaceuticals Inc.1999-05-01Not applicableUS flag
CatapresPatch, extended release0.1 mg/24hTransdermalPhysicians Total Care, Inc.1994-12-092012-06-30US flag
CatapresTablet0.200 mg/1OralBoehringer Ingelheim Promeco s.a. De c.v.1999-05-012013-03-25US flag
CatapresTablet0.1 mg/1OralREMEDYREPACK INC.2016-10-112018-01-09US flag
CatapresTablet0.200 mg/1OralBoehringer Ingelheim Pharmaceuticals Inc.1999-05-01Not applicableUS flag
CatapresPatch, extended release0.1 mg/24hTransdermalRebel Distributors1985-10-01Not applicableUS flag
CatapresPatch, extended release0.3 mg/24hTransdermalPhysicians Total Care, Inc.2004-07-082012-06-30US flag
CatapresTablet0.100 mg/1OralBoehringer Ingelheim Promeco s.a. De c.v.1999-05-012013-03-25US flag
CatapresTablet0.200 mg/1OralPhysicians Total Care, Inc.1974-09-032011-06-30US flag
CatapresPatch, extended release0.2 mg/24hTransdermalPhysicians Total Care, Inc.1994-10-112011-06-30US flag
CatapresTablet0.100 mg/1OralBoehringer Ingelheim Pharmaceuticals Inc.1999-05-01Not applicableUS flag
CatapresTablet.300 mg/1OralBoehringer Ingelheim Promeco s.a. De c.v.1999-05-012013-03-25US flag
Catapres Tab 0.1mgTablet0.1 mgOralBoehringer Ingelheim (Canada) Ltd Ltee1973-12-312017-02-15Canada flag
Catapres Tab 0.2mgTablet0.2 mgOralBoehringer Ingelheim (Canada) Ltd Ltee1974-12-312015-03-30Canada flag
Catapres-TTSPatch0.1 mg/1dTransdermalBoehringer Ingelheim Pharmaceuticals Inc.1985-10-012023-12-31US flag
Catapres-TTSPatch0.3 mg/1dTransdermalBoehringer Ingelheim Pharmaceuticals Inc.1985-10-012023-12-31US flag
Catapres-TTSPatch0.2 mg/1dTransdermalBoehringer Ingelheim Pharmaceuticals Inc.1985-10-012023-12-31US flag
Catapres-TTS-1Patch0.1 mg/1dTransdermalTechnomed Inc.2022-03-012026-10-30US flag
Catapres-TTS-2Patch0.2 mg/1dTransdermalTechnomed Inc.2022-03-012026-10-30US flag
Catapres-TTS-3Patch0.3 mg/1dTransdermalTechnomed Inc.2022-03-012026-10-30US flag
ClonidineTablet0.025 mgOralSivem Pharmaceuticals Ulc2024-02-02Not applicableCanada flag
ClonidineTablet0.025 mgOralSanis Health Inc2011-02-082012-08-03Canada flag
ClonidineTablet0.2 mgOralSanis Health Inc2011-02-082012-08-03Canada flag
ClonidineTablet0.2 mgOralSivem Pharmaceuticals Ulc2024-02-02Not applicableCanada flag
ClonidineTablet0.1 mgOralSanis Health Inc2011-02-082012-08-03Canada flag
ClonidineTablet0.1 mgOralSivem Pharmaceuticals Ulc2024-02-02Not applicableCanada flag
Clonidine 0.1Tablet0.1 mgOralPro Doc Limitee1991-12-312014-07-24Canada flag
Clonidine HCl Tab 0.2mgTablet.2 mgOralPro Doc Limitee1991-12-312014-07-24Canada flag
Clonidine HydrochlorideTablet0.200 mg/1OralVintage Pharmaceuticals, LLC2007-05-112007-05-11US flag
Clonidine HydrochlorideTablet0.100 mg/1OralVintage Pharmaceuticals, LLC2007-05-112007-05-11US flag
Clonidine HydrochlorideTablet0.300 mg/1OralVintage Pharmaceuticals, LLC2007-05-112007-05-11US flag
Clonidine HydrochlorideTablet0.3 mg/1OralState of Florida DOH Central Pharmacy2009-06-20Not applicableUS flag
Clonidine hydrochloride extended-releaseTablet, extended release0.1 mg/1OralConcordia Pharmaceuticals, Inc2010-12-092017-03-31US flag
Clonidine Transdermal System USP, 0.1 mg/dayPatch0.1 mg/1dTransdermalTrupharma, Llc2023-06-30Not applicableUS flag
Clonidine Transdermal System USP, 0.2 mg/dayPatch0.2 mg/1dTransdermalTrupharma, Llc2023-06-30Not applicableUS flag
Clonidine Transdermal System USP, 0.3 mg/dayPatch0.3 mg/1dTransdermalTrupharma, Llc2023-06-30Not applicableUS flag
Dixarit Tab 0.025mgTablet0.025 mgOralBoehringer Ingelheim (Canada) Ltd Ltee1981-12-312016-10-22Canada flag
DuraclonInjection, solution0.5 mg/1mLIntravenousXanodyne Pharmaceuticals2013-05-132013-05-23US flag
DuraclonInjection, solution0.1 mg/1mLEpiduralMylan Institutional LLC1997-01-26Not applicableUS flag
DuraclonInjection, solution0.1 mg/1mLIntravenousXanodyne Pharmaceuticals2013-05-132013-05-23US flag
DuraclonInjection, solution0.5 mg/1mLIntravenousBioniche Pharma USA LLC2010-09-082010-09-10US flag
KapvayTablet, extended release0.1 mg/1OralShionogi Pharma, Inc.2010-12-092010-12-16US flag
KapvayTablet, extended release0.2 mg/1OralShionogi2010-12-092014-08-31US flag
KapvayTablet, extended release0.2 mg/1OralConcordia Pharmaceuticals Inc.2010-12-092014-11-27US flag
KapvayTablet, extended release0.1 mg/1OralShionogi2010-12-092014-04-30US flag
KapvayTablet, extended release0.1 mg/1OralConcordia Pharmaceuticals Inc.2010-12-09Not applicableUS flag
NexiclonTablet, extended release0.17 mg/1OralTris Pharma, Inc.2010-12-172016-11-18US flag
Nexiclon XRTablet, extended release0.17 mg/1OralNext Wave Pharmaceuticals, Inc.2010-12-152012-11-30US flag
Nexiclon XRTablet, extended release0.26 mg/1OralTris Pharma, Inc.2010-12-172016-11-18US flag
Nexiclon XRTablet, extended release0.17 mg/1OralAthena Bioscience, LLC2022-03-01Not applicableUS flag
Nexiclon XRSuspension, extended release0.09 mg/1mLOralNext Wave Pharmaceuticals, Inc.2010-12-152012-10-31US flag
Nexiclon XRFor suspension, extended release0.09 mg/1mLOralTris Pharma, Inc.2010-12-172016-11-18US flag
Nexiclon XRTablet, extended release0.26 mg/1OralNext Wave Pharmaceuticals, Inc.2010-12-152012-11-30US flag
Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Apo-clonidineTablet0.025 mgOralApotex Corporation2004-07-13Not applicableCanada flag
Apo-clonidine Tab 0.1mgTablet0.1 mgOralApotex Corporation1990-12-31Not applicableCanada flag
Apo-clonidine Tab 0.2mgTablet0.2 mgOralApotex Corporation1990-12-31Not applicableCanada flag
ClonidinePatch, extended release0.3 mg/24hTransdermalTeva2010-08-252018-03-31US flag
ClonidinePatch, extended release0.3 mg/24hTransdermalMayne Pharma Inc.2016-08-03Not applicableUS flag
ClonidinePatch0.3 mg/1dTransdermalMylan Pharmaceuticals Inc.2013-03-01Not applicableUS flag
ClonidinePatch0.1 mg/1dTransdermalPhysicians Total Care, Inc.2011-09-24Not applicableUS flag
ClonidinePatch, extended release0.2 mg/24hTransdermalDr. Reddy's Labratories Inc.2024-02-10Not applicableUS flag
ClonidinePatch0.3 mg/1dTransdermalPar Pharmaceutical2009-08-202012-05-31US flag
ClonidinePatch, extended release0.2 mg/24hTransdermalLake Erie Medical Dba Quality Care Produts Llc2010-08-252016-06-01US flag
ClonidinePatch, extended release0.2 mg/24hTransdermalTeva2010-08-252018-01-31US flag
ClonidinePatch, extended release0.1 mg/24hTransdermalCorium International, Inc.2016-08-03Not applicableUS flag
ClonidinePatch0.2 mg/1dTransdermalMylan Pharmaceuticals Inc.2013-03-04Not applicableUS flag
ClonidineTablet, extended release0.17 mg/1OralPalmetto Pharmaceuticals Inc.2022-03-01Not applicableUS flag
ClonidineInjection, solution500 ug/1mLEpiduralXGen Pharmaceuticals DJB, Inc.2013-10-29Not applicableUS flag
ClonidinePatch, extended release0.3 mg/24hTransdermalCorium International, Inc.2016-08-03Not applicableUS flag
ClonidinePatch, extended release0.2 mg/24hTransdermalMayne Pharma Inc.2016-08-03Not applicableUS flag
ClonidinePatch0.3 mg/1dTransdermalPhysicians Total Care, Inc.2011-05-10Not applicableUS flag
ClonidinePatch, extended release0.1 mg/24hTransdermalDr. Reddy's Labratories Inc.2024-02-10Not applicableUS flag
ClonidinePatch0.2 mg/1dTransdermalPar Pharmaceutical2009-08-202012-06-30US flag
ClonidinePatch, extended release0.1 mg/24hTransdermalTeva2010-08-252018-04-30US flag
ClonidinePatch, extended release0.1 mg/24hTransdermalMayne Pharma Inc.2016-08-03Not applicableUS flag
ClonidinePatch0.2 mg/1dTransdermalPhysicians Total Care, Inc.2010-12-14Not applicableUS flag
ClonidinePatch0.1 mg/1dTransdermalMylan Pharmaceuticals Inc.2013-02-25Not applicableUS flag
ClonidineInjection, solution500 ug/1mLEpiduralFresenius Kabi USA, LLC2011-07-082016-11-07US flag
ClonidineInjection, solution100 ug/1mLEpiduralXGen Pharmaceuticals DJB, Inc.2013-10-29Not applicableUS flag
ClonidinePatch, extended release0.2 mg/24hTransdermalCorium International, Inc.2016-08-03Not applicableUS flag
ClonidinePatch0.2 mg/1dTransdermalLake Erie Medical Dba Quality Care Produts Llc2013-02-082015-12-31US flag
ClonidinePatch0.1 mg/1dTransdermalPar Pharmaceutical2009-08-202012-06-30US flag
ClonidinePatch, extended release0.3 mg/24hTransdermalDr. Reddy's Labratories Inc.2024-02-10Not applicableUS flag
ClonidineTablet, extended release0.1 mg/1OralIngenus Pharmaceuticals, LLC2019-03-05Not applicableUS flag
ClonidineTablet0.1 mg/1OralStat Rx USA1986-12-16Not applicableUS flag
ClonidineTablet, extended release0.17 mg/1OralTrupharma, Llc2024-01-11Not applicableUS flag
Clonidine HciInjection, solution100 ug/1mLIntravenousHF Acquisition Co LLC, DBA HealthFirst2018-12-23Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralDenton Pharma, Inc. Dba Northwind Pharmaceuticals2020-04-142023-07-31US flag
Clonidine HydrochlorideTablet0.2 mg/1OralMylan Pharmaceuticals Inc.1987-06-092020-09-30US flag
Clonidine HydrochlorideTablet0.2 mg/1OralGolden State Medical Supply, Inc.2017-01-032017-10-10US flag
Clonidine HydrochlorideTablet0.2 mg/1OralImpax Generics2009-12-012016-11-14US flag
Clonidine HydrochlorideTablet0.1 mg/1OralMajor Pharmaceuticals2006-11-202021-03-31US flag
Clonidine HydrochlorideTablet0.3 mg/1OralA S Medication Solutions2013-02-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralPd Rx Pharmaceuticals, Inc.2013-06-172018-01-19US flag
Clonidine HydrochlorideTablet0.1 mg/1OralPreferred Pharmaceuticals, Inc.2015-04-13Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralGeneral Injectables & Vaccines, Inc2010-03-012021-03-31US flag
Clonidine HydrochlorideTablet0.3 mg/1OralPD-Rx Pharmaceuticals, Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.100 mg/1OralState of Florida DOH Central Pharmacy2009-07-01Not applicableUS flag
Clonidine hydrochlorideTablet0.3 mg/1OralAphena Pharma Solutions - Tennessee, LLC2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralCardinal Health2011-07-08Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralClinical Solutions Wholsesale2007-03-092017-06-23US flag
Clonidine HydrochlorideTablet0.1 mg/1OralPreferred Pharmaceuticals, Inc.2011-11-102019-08-08US flag
Clonidine HydrochlorideTablet0.3 mg/1OralMutual Pharmaceutical1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2021-12-14Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralPD-Rx Pharmaceuticals, Inc.1987-06-092019-06-17US flag
Clonidine HydrochlorideTablet0.1 mg/1OralLake Erie Medical DBA Quality Care Products LLC1995-01-032019-10-11US flag
Clonidine HydrochlorideTablet0.1 mg/1OralNorthwind Pharmaceuticals, LLC2015-02-25Not applicableUS flag
Clonidine hydrochlorideTablet0.2 mg/1OralAsclemed Usa, Inc.2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralA-S Medication Solutions2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralREMEDYREPACK INC.2015-07-312017-12-28US flag
Clonidine HydrochlorideTablet0.3 mg/1OralRemedy Repack2010-07-162014-06-18US flag
Clonidine HydrochlorideTablet0.1 mg/1OralPhysicians Total Care, Inc.2001-10-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2012-08-162017-06-15US flag
Clonidine HydrochlorideTablet, extended release0.2 mg/1OralActavis Pharma, Inc.2015-06-172015-06-17US flag
Clonidine hydrochlorideTablet0.1 mg/1OralTrupharma, Llc2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralMcKesson Corporation dba SKY Packaging1995-01-032021-08-31US flag
Clonidine HydrochlorideTablet0.2 mg/1OralState of Florida DOH Central Pharmacy2009-07-01Not applicableUS flag
Clonidine hydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1Oralbryant ranch prepack2015-06-17Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralDirectrx2015-01-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralNorthwind Pharmaceuticals2014-09-24Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralSt. Mary's Medical Park Pharmacy2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2017-03-012018-07-28US flag
Clonidine HydrochlorideTablet0.300 mg/1Oralbryant ranch prepack2007-03-092017-12-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralH. J. Harkins Company Inc.2017-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.200 mg/1OralAidarex Pharmaceuticals LLC2007-03-09Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2019-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralPreferred Pharmaceuticals, Inc.2011-11-102019-08-09US flag
Clonidine HydrochlorideTablet0.200 mg/1OralQualitest2007-03-092017-07-31US flag
Clonidine HydrochlorideTablet0.3 mg/1OralA-S Medication Solutions2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralAmerincan Health Packaging2005-06-082017-06-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralDirectrx2019-04-04Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralContract Pharmacy Services Pa2010-08-18Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralAlembic Pharmaceuticals Limited2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralMethod Pharmaceuticals, LLC2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralMcKesson Packaging Services Business Unit of McKesson Corporation2007-09-052010-03-01US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2015-07-222016-10-29US flag
Clonidine HydrochlorideTablet0.1 mg/1OralGeneral Injectables & Vaccines, Inc.2019-10-102020-09-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralDirectrx2015-01-01Not applicableUS flag
Clonidine HydrochlorideTablet0.100 mg/1OralA S Medication Solutions2007-03-09Not applicableUS flag
Clonidine hydrochlorideTablet0.2 mg/1OralProficient Rx LP2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralNucare Pharmaceuticals,inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralSt Marys Medical Park Pharmacy2010-03-012018-06-30US flag
Clonidine HydrochlorideTablet0.100 mg/1Oralbryant ranch prepack2007-03-092017-07-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2014-03-042015-12-11US flag
Clonidine HydrochlorideTablet0.100 mg/1OralTYA Pharmaceuticals2007-03-09Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralAurobindo Pharma Limited2021-06-02Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralNCS HealthCare of KY, Inc dba Vangard Labs2018-07-102020-05-31US flag
Clonidine HydrochlorideTablet0.2 mg/1OralPD-Rx Pharmaceuticals, Inc.1987-06-092019-09-11US flag
Clonidine HydrochlorideTablet0.3 mg/1OralCarlsbad Technology, Inc.2013-06-17Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2018-11-07Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralMed Pharma Co., Ltd.2010-07-292012-11-08US flag
Clonidine HydrochlorideTablet0.1 mg/1OralUnichem Pharmaceuticals (USA), Inc.2020-12-24Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralAmerican Health Packaging2020-07-29Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralHF Acquisition Co LLC, DBA HealthFirst2020-04-06Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralUnichem Pharmaceuticals (USA), Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralPreferred Pharmaceuticals Inc.2021-10-05Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralMc Kesson Contract Packaging2011-10-032017-09-30US flag
Clonidine HydrochlorideTablet0.2 mg/1Oralbryant ranch prepack1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralCardinal Health2006-11-202021-03-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRedPharm Drug, Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideInjection, solution500 ug/1mLIntravenousHikma Farmaceutica2011-01-012011-01-01US flag
Clonidine HydrochlorideTablet0.2 mg/1OralAvPAK2023-05-30Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralUnit Dose Services1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralActavis Pharma, Inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralUnit Dose Services2009-09-212016-08-05US flag
Clonidine HydrochlorideTablet0.3 mg/1OralA-S Medication Solutions2013-06-172018-03-31US flag
Clonidine HydrochlorideTablet0.2 mg/1OralRemedy Repack2010-07-152014-03-27US flag
Clonidine HydrochlorideTablet0.200 mg/1OralState of Florida DOH Central Pharmacy2014-01-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions2020-12-24Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralMylan Institutional Inc.1997-02-142020-09-30US flag
Clonidine HydrochlorideTablet0.2 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1Oralmedsource pharmaceuticals2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.300 mg/1OralA-S Medication Solutions2007-03-092016-08-31US flag
Clonidine HydrochlorideTablet0.2 mg/1Oralbryant ranch prepack1995-01-032017-04-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralMed Vantx, Inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralMarlex Pharmaceuticals Inc2020-10-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralSt. Marys Medical Park Pharmacy2014-01-232017-09-30US flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralLupin Pharmaceuticals, Inc.2018-02-07Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralNucare Pharmaceuticals, Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2021-07-19Not applicableUS flag
Clonidine HydrochlorideTablet0.100 mg/1OralPreferred Pharmaceuticals, Inc.2014-10-222019-08-08US flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2017-05-03Not applicableUS flag
Clonidine hydrochlorideTablet0.3 mg/1OralTrupharma, Llc2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNorthwind Pharmaceuticals2021-02-05Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralA-S Medication Solutions1995-01-032016-10-05US flag
Clonidine HydrochlorideTablet0.1 mg/1OralCardinal Health2011-07-08Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2015-11-052018-08-29US flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2009-01-162017-12-13US flag
Clonidine HydrochlorideTablet0.2 mg/1OralMutual Pharmaceutical1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack2020-12-24Not applicableUS flag
Clonidine HydrochlorideInjection, solution0.5 mg/1mLEpiduralZydus Lifesciences Limited2018-01-31Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralMed Pharma Co., Ltd.2011-01-10Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralA-S Medication Solutions1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.200 mg/1OralUnit Dose Services2007-03-092017-12-31US flag
Clonidine HydrochlorideTablet0.3 mg/1OralDAVA Pharmaceuticals, Inc.1988-04-052014-04-01US flag
Clonidine HydrochlorideTablet0.2 mg/1OralAlembic Pharmaceuticals Inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralRebel Distributors1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralRpk Pharmaceuticals, Inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralAmneal Pharmaceuticals NY LLC2017-11-29Not applicableUS flag
Clonidine HydrochlorideTablet0.200 mg/1OralSolco Healthcare Llc2023-01-05Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralCardinal Health 107, LLC2020-07-30Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralPreferred Pharmaceuticals, Inc.2011-11-102019-08-08US flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralJubilant Cadista Pharmaceuticals Inc.2018-01-29Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralRemedy Repack2014-07-212017-06-29US flag
Clonidine HydrochlorideTablet0.2 mg/1OralPreferred Pharmaceuticals Inc.2018-09-24Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1Oralbryant ranch prepack2009-09-21Not applicableUS flag
Clonidine hydrochlorideTablet, extended release0.1 mg/1OralBluePoint Laboratories2023-08-24Not applicableUS flag
Clonidine hydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralCardinal Health2009-09-032016-07-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralNorth Star Rx Llc2013-02-042015-10-31US flag
Clonidine HYDROCHLORIDETablet0.1 mg/1OralApotheca, Inc.1996-12-21Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralMajor Pharmaceuticals2006-11-202021-02-28US flag
Clonidine HydrochlorideTablet0.2 mg/1OralRichmond Pharmaceuticals1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralClinical Solutions Wholesale, LLC2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralBluePoint Laboratories1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralLake Erie Medical DBA Quality Care Products LLC2013-06-172019-12-31US flag
Clonidine HydrochlorideTablet.2 mg/1OralBlenheim Pharmacal, Inc.2013-11-15Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralProficient Rx LP2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralBlenheim Pharmacal, Inc.2010-04-08Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1Oralbryant ranch prepack2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralClinical Solutions Wholsesale2007-03-092017-06-23US flag
Clonidine HydrochlorideTablet0.1 mg/1OralHF Acquisition Co LLC, DBA HealthFirst2018-11-30Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralContract Pharmacy Services-PA2020-01-09Not applicableUS flag
Clonidine HydrochlorideInjection, solution100 ug/1mLEpiduralFresenius Kabi USA, LLC2011-07-082016-11-07US flag
Clonidine HydrochlorideTablet0.2 mg/1OralPd Rx Pharmaceuticals, Inc.2013-06-172018-01-18US flag
Clonidine HydrochlorideTablet0.2 mg/1OralRemedy Repack2009-12-022014-10-03US flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2017-03-22Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralMylan Institutional Inc.1995-06-122020-02-29US flag
Clonidine HydrochlorideTablet0.1 mg/1OralMylan Pharmaceuticals Inc.1987-06-092020-09-30US flag
Clonidine HydrochlorideTablet0.2 mg/1OralMcKesson Packaging Services Business Unit of McKesson Corporation2007-06-122010-03-01US flag
Clonidine HydrochlorideTablet0.1 mg/1OralGolden State Medical Supply, Inc.2017-01-032020-01-29US flag
Clonidine hydrochlorideTablet0.1 mg/1OralA-S Medication Solutions2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralImpax Generics2009-12-012016-11-14US flag
Clonidine HydrochlorideTablet0.100 mg/1OralDispensing Solutions, Inc.2007-03-09Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralPreferred Pharmaceuticals Inc.2023-07-26Not applicableUS flag
Clonidine hydrochlorideTablet, extended release0.1 mg/1OralQuality Care Products, LLC2019-10-11Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralPhysicians Total Care, Inc.2004-11-30Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralNCS HealthCare of KY, LLC dba Vangard Labs1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2015-09-012018-02-07US flag
Clonidine HydrochlorideTablet.3 mg/1OralBlenheim Pharmacal, Inc.2011-04-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralPD-Rx Pharmaceuticals, Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralState of Florida DOH Central Pharmacy2009-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralRemedy Repack2015-06-152017-03-07US flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralREMEDYREPACK INC.2021-11-28Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralUnit Dose Services2009-09-212016-08-05US flag
Clonidine HydrochlorideTablet0.3 mg/1OralAmerincan Health Packaging2005-08-082016-12-31US flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralActavis Pharma, Inc.2015-06-17Not applicableUS flag
Clonidine HydrochlorideInjection, solution0.5 mg/1mLEpiduralZydus Pharmaceuticals USA Inc.2018-01-31Not applicableUS flag
Clonidine HydrochlorideInjection, solution100 ug/1mLIntravenousHikma Farmaceutica2011-01-012011-01-01US flag
Clonidine hydrochlorideTablet0.1 mg/1OralAsclemed Usa, Inc.2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions2020-12-24Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralMc Kesson Contract Packaging1995-01-032017-09-30US flag
Clonidine HydrochlorideInjection, solution500 ug/1mLEpiduralAMERICAN REGENT, INC.2010-04-152016-03-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2017-12-12Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2015-07-142016-07-14US flag
Clonidine HydrochlorideTablet0.1 mg/1OralAvPAK2023-05-30Not applicableUS flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralREMEDYREPACK INC.2019-05-23Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralRpk Pharmaceuticals, Inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralLake Erie Medical DBA Quality Care Products LLC2010-05-192014-06-01US flag
Clonidine HydrochlorideTablet0.1 mg/1OralAidarex Pharmaceuticals LLC1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralAlembic Pharmaceuticals Limited2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralState of Florida DOH Central Pharmacy2009-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralMethod Pharmaceuticals, LLC2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralCardinal Health2013-06-172015-12-15US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRedPharm Drug, Inc.2018-01-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2018-02-272020-05-11US flag
Clonidine HydrochlorideTablet0.3 mg/1OralAmerincan Health Packaging2015-10-012018-02-28US flag
Clonidine HydrochlorideTablet0.3 mg/1OralNorth Star Rx Llc2013-02-042015-10-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralSt. Mary's Medical Park Pharmacy2018-03-02Not applicableUS flag
Clonidine HydrochlorideInjection, solution0.1 mg/1mLEpiduralZydus Lifesciences Limited2018-01-31Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralMed Pharma Co., Ltd.2011-01-10Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralAurobindo Pharma Limited2021-06-02Not applicableUS flag
Clonidine hydrochlorideTablet0.1 mg/1OralProficient Rx LP2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralProficient Rx LP1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralLake Erie Medical Dba Quality Care Produts Llc2008-06-012016-06-01US flag
Clonidine HydrochlorideTablet0.2 mg/1OralLake Erie Medical DBA Quality Care Products LLC1995-01-032019-10-11US flag
Clonidine hydrochlorideTablet, extended release0.1 mg/1OralAjanta Pharma USA Inc.2017-11-21Not applicableUS flag
Clonidine HydrochlorideTablet0.100 mg/1OralQualitest2007-03-092018-09-23US flag
Clonidine hydrochlorideTablet0.1 mg/1OralNorthwind Pharmaceuticals2020-10-01Not applicableUS flag
Clonidine hydrochlorideTablet, extended release0.1 mg/1OralAmerican Health Packaging2019-11-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralMed Pharma Co., Ltd.2010-07-292012-11-08US flag
Clonidine HydrochlorideTablet0.2 mg/1OralDenton Pharma, Inc. Dba Northwind Pharmaceuticals2019-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralActavis Pharma, Inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2016-04-112017-04-11US flag
Clonidine HydrochlorideTablet0.2 mg/1OralCardinal Health1986-12-162012-10-31US flag
Clonidine HydrochlorideInjection, solution500 ug/1mLEpiduralPharma Force, Inc.2009-10-16Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2019-03-14Not applicableUS flag
Clonidine hydrochlorideTablet0.2 mg/1OralA-S Medication Solutions2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralCardinal Health2009-09-032014-05-30US flag
Clonidine HydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralGolden State Medical Supply, Inc.2017-01-032017-10-10US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2015-01-292016-08-13US flag
Clonidine HydrochlorideTablet0.3 mg/1OralImpax Generics2009-12-012016-11-14US flag
Clonidine HydrochlorideTablet0.1 mg/1OralNCS HealthCare of KY, LLC dba Vangard Labs1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralMajor Pharmaceuticals2006-11-202020-07-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRichmond Pharmaceuticals1987-09-04Not applicableUS flag
Clonidine hydrochlorideTablet0.2 mg/1OralNorthwind Pharmaceuticals2022-04-15Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralCardinal Health 107, LLC2020-07-29Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralNCS HealthCare of KY, Inc dba Vangard Labs2009-09-212020-11-30US flag
Clonidine HydrochlorideTablet0.3 mg/1OralPd Rx Pharmaceuticals, Inc.2013-06-172018-01-19US flag
Clonidine hydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2018-07-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralPreferred Pharmaceuticals Inc.2016-08-31Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralCarlsbad Technology, Inc.2013-06-17Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralStat Rx USA2009-09-03Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralMylan Pharmaceuticals Inc.1987-06-092020-09-30US flag
Clonidine HydrochlorideTablet0.2 mg/1OralMarlex Pharmaceuticals Inc2020-10-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions2013-06-172018-03-31US flag
Clonidine HydrochlorideTablet0.300 mg/1OralState of Florida DOH Central Pharmacy2013-01-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions2020-12-24Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralUnichem Pharmaceuticals (USA), Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralA-S Medication Solutions2016-05-032018-02-28US flag
Clonidine HydrochlorideTablet0.2 mg/1OralRemedy Repack2014-11-062015-11-20US flag
Clonidine hydrochlorideTablet0.1 mg/1Oralbryant ranch prepack2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralCardinal Health2011-07-082019-04-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2015-11-042017-04-06US flag
Clonidine HydrochlorideTablet0.2 mg/1OralAidarex Pharmaceuticals LLC2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralNorthStar Rx LLC2018-06-18Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralREMEDYREPACK INC.2019-07-10Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralPhysicians Total Care, Inc.1995-01-09Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralPreferred Pharmaceuticals Inc.2022-04-04Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideInjection, solution500 ug/1mLIntravenousHikma Pharmaceuticals USA Inc.2011-01-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2015-03-172016-04-16US flag
Clonidine HydrochlorideTablet0.200 mg/1OralA-S Medication Solutions2007-03-092016-12-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralPreferred Pharmaceuticals Inc.2018-04-23Not applicableUS flag
Clonidine hydrochlorideTablet0.3 mg/1OralAsclemed Usa, Inc.2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralPD-Rx Pharmaceuticals, Inc.1987-06-09Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralRebel Distributors1987-09-04Not applicableUS flag
Clonidine hydrochlorideTablet0.1 mg/1OralQuality Care Products, LLC2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralRpk Pharmaceuticals, Inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralPD-Rx Pharmaceuticals, Inc.1987-06-092019-09-12US flag
Clonidine HydrochlorideTablet0.1 mg/1OralPD-Rx Pharmaceuticals, Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralMutual Pharmaceutical1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions2021-06-02Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralNucare Pharmaceuticals, Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2019-01-302020-06-01US flag
Clonidine hydrochlorideTablet0.2 mg/1OralTrupharma, Llc2017-06-01Not applicableUS flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralXiamen Lp Pharmaceutical Co., Ltd.2017-12-01Not applicableUS flag
Clonidine HydrochlorideTablet0.300 mg/1OralQualitest2007-03-092017-07-31US flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralSolco Healthcare Llc2018-02-15Not applicableUS flag
Clonidine HydrochlorideTablet0.100 mg/1OralSolco Healthcare Llc2023-01-05Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralBluePoint Laboratories1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralAmerincan Health Packaging2005-08-082017-03-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralUnit Dose Services1995-01-032017-12-31US flag
Clonidine HydrochlorideTablet0.3 mg/1OralDirectrx2015-12-292023-12-31US flag
Clonidine HydrochlorideTablet0.2 mg/1OralDAVA Pharmaceuticals, Inc.1988-04-052014-04-01US flag
Clonidine HydrochlorideTablet0.1 mg/1OralAlembic Pharmaceuticals Inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralContract Pharmacy Services Pa2010-07-29Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals, Inc.2009-09-21Not applicableUS flag
Clonidine hydrochlorideTablet0.3 mg/1OralDenton Pharma, Inc. Dba Northwind Pharmaceuticals2020-05-282023-01-31US flag
Clonidine HydrochlorideInjection, solution100 ug/1mLEpiduralAMERICAN REGENT, INC.2010-04-152015-02-26US flag
Clonidine HydrochlorideTablet0.200 mg/1OralA S Medication Solutions2007-03-09Not applicableUS flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1Oralbryant ranch prepack2018-02-15Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralClinical Solutions Wholesale, LLC2009-09-212018-12-01US flag
Clonidine HydrochlorideTablet0.1 mg/1OralPD-Rx Pharmaceuticals, Inc.1987-09-042018-08-28US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2012-11-302014-04-01US flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralNucare Pharmaceuticals,inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralClinical Solutions Wholsesale2007-03-092017-06-23US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2015-02-112016-02-11US flag
Clonidine HydrochlorideTablet0.1 mg/1OralProficient Rx LP2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2018-11-27Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralMed Pharma Co., Ltd.2010-07-292012-11-08US flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1Oralbryant ranch prepack2018-02-15Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralAmerican Health Packaging2020-07-30Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralA-S Medication Solutions1987-09-042018-06-30US flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralUpsher-Smith Laboratories, LLC2018-10-122021-06-30US flag
Clonidine HydrochlorideTablet.1 mg/1OralBlenheim Pharmacal, Inc.2013-11-15Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralAurobindo Pharma Limited2021-06-02Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralREMEDYREPACK INC.2019-01-23Not applicableUS flag
Clonidine HydrochlorideTablet0.200 mg/1OralState of Florida DOH Central Pharmacy2009-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralNucare Pharmaceuticals,inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralNorthwind Pharmaceuticals, LLC2020-05-27Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralREMEDYREPACK INC.2018-03-132020-05-11US flag
Clonidine HydrochlorideTablet0.2 mg/1OralCardinal Health2006-11-202021-06-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralMed Vantx, Inc.2011-12-13Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralAvPAK2023-05-30Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralDenton Pharma, Inc. Dba Northwind Pharmaceuticals2019-02-13Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2012-07-182012-08-23US flag
Clonidine HydrochlorideTablet0.2 mg/1OralMylan Institutional Inc.1995-06-122020-09-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralLake Erie Medical &Surgical Supply Dba Quality Care Products Llc2010-12-312016-12-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralRemedy Repack2011-04-042012-04-04US flag
Clonidine HydrochlorideTablet0.2 mg/1OralCarlsbad Technology, Inc.2013-06-17Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.100 mg/1OralDispensing Solutions, Inc.2007-03-09Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralMarlex Pharmaceuticals Inc2020-10-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralSt. Marys Medical Park Pharmacy2014-01-232016-12-31US flag
Clonidine HydrochlorideTablet0.3 mg/1OralREMEDYREPACK INC.2018-02-02Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralNCS HealthCare of KY, LLC dba Vangard Labs1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralNcs Health Care Of Ky, Inc Dba Vangard Labs1986-12-16Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralREMEDYREPACK INC.2019-03-18Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralState of Florida DOH Central Pharmacy2009-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNCS HealthCare of KY, Inc dba Vangard Labs2009-09-212020-11-30US flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.2016-05-032019-12-31US flag
Clonidine HydrochlorideTablet0.2 mg/1OralPreferred Pharmaceuticals, Inc.2020-04-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1Oralbryant ranch prepack2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet, extended release25 mg/1OralBluepharma - Industria Farmaceutica, S.A.2019-03-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralUnit Dose Services2009-09-212016-08-05US flag
Clonidine HydrochlorideInjection, solution0.1 mg/1mLEpiduralZydus Pharmaceuticals USA Inc.2018-01-31Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralMed Pharma Co., Ltd.2011-01-10Not applicableUS flag
Clonidine hydrochlorideTablet0.1 mg/1OralDenton Pharma, Inc. Dba Northwind Pharmaceuticals2021-04-122024-10-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralDirect Rx2014-01-01Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralAlembic Pharmaceuticals Inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralRebel Distributors1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralDenton Pharma, Inc. Dba Northwind Pharmaceuticals2020-10-09Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralRpk Pharmaceuticals, Inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals, Inc.1987-09-042019-12-31US flag
Clonidine HydrochlorideTablet, extended release0.1 mg/1OralMayne Pharma Inc.2018-06-27Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralTYA Pharmaceuticals1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.300 mg/1OralSolco Healthcare Llc2023-01-05Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralAlembic Pharmaceuticals Limited2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralState of Florida DOH Central Pharmacy2009-07-01Not applicableUS flag
Clonidine HydrochlorideInjection, solution100 ug/1mLIntravenousHikma Pharmaceuticals USA Inc.2011-01-01Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralMethod Pharmaceuticals, LLC2020-07-01Not applicableUS flag
Clonidine HydrochlorideTablet0.100 mg/1OralA-S Medication Solutions2007-03-092015-12-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralNucare Pharmaceuticals,inc.2009-09-21Not applicableUS flag
Clonidine hydrochlorideTablet0.3 mg/1OralNorthwind Pharmaceuticals, LLC2022-12-06Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralA-S Medication Solutions1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralClinical Solutions Wholesale, LLC2009-09-212018-12-07US flag
Clonidine HydrochlorideTablet0.2 mg/1OralNorth Star Rx Llc2013-02-042015-10-31US flag
Clonidine HydrochlorideTablet0.3 mg/1OralRichmond Pharmaceuticals1987-09-04Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralProficient Rx LP2020-12-24Not applicableUS flag
Clonidine HydrochlorideTablet0.100 mg/1OralLake Erie Medical Dba Quality Care Produts Llc2007-03-092014-12-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralDAVA Pharmaceuticals, Inc.1988-04-052014-04-01US flag
Clonidine HydrochlorideTablet0.1 mg/1Oralbryant ranch prepack2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralA-S Medication Solutions1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralAsclemed Usa, Inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralActavis Pharma, Inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralAphena Pharma Solutions Tennessee, Inc.1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralA-S Medication Solutions2013-06-172018-07-31US flag
Clonidine HydrochlorideTablet0.1 mg/1OralCardinal Health1986-12-162012-10-31US flag
Clonidine hydrochlorideTablet, extended release0.1 mg/1OralREMEDYREPACK INC.2022-01-31Not applicableUS flag
Clonidine HydrochlorideInjection, solution100 ug/1mLEpiduralPharma Force, Inc.2009-10-16Not applicableUS flag
Clonidine HydrochlorideTablet0.3 mg/1OralUnichem Pharmaceuticals (USA), Inc.2009-09-21Not applicableUS flag
Clonidine HydrochlorideTablet0.2 mg/1OralBluePoint Laboratories1995-01-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralPD-Rx Pharmaceuticals, Inc.2016-05-03Not applicableUS flag
Clonidine HydrochlorideTablet0.1 mg/1OralAvera McKennan Hospital2015-03-052017-05-24US flag
Clonidine HydrochlorideTablet0.1 mg/1OralContract Pharmacy Services Pa2017-09-28Not applicableUS flag
Clonidine hydrochloride extended-releaseTablet, extended release0.1 mg/1OralPrasco Laboratories2016-06-20Not applicableUS flag
Clonidine Hydrochloride Extended-ReleaseTablet, extended release0.1 mg/1OralPar Pharmaceutical, Inc.2013-09-302023-04-30US flag
Clonidine Hydrochloride Extended-ReleaseTablet, extended release0.1 mg/1OralAmerican Health Packaging2014-10-212020-06-30US flag
Clonidine Hydrochloride Extended-ReleaseTablet, extended release0.1 mg/1OralAvKARE2018-09-13Not applicableUS flag
Clonidine Hydrochloride Extended-ReleaseTablet, extended release0.2 mg/1OralPar Pharmaceutical, Inc.2013-09-302013-09-30US flag
Clonidine Hydrochloride Extended-ReleaseTablet, extended release0.1 mg/1OralGolden State Medical Supply, Inc.2013-09-302023-04-30US flag
Clonidine transdermal systemPatch0.3 mg/1dTransdermalActavis Pharma, Inc.2014-05-06Not applicableUS flag
Clonidine transdermal systemPatch0.2 mg/1dTransdermalActavis Pharma, Inc.2014-05-06Not applicableUS flag
Clonidine transdermal systemPatch0.1 mg/1dTransdermalActavis Pharma, Inc.2014-05-06Not applicableUS flag
Dom-clonidineTablet.2 mgOralDominion Pharmacal2003-05-22Not applicableCanada flag
Dom-clonidineTablet.1 mgOralDominion Pharmacal2003-05-22Not applicableCanada flag
Jamp ClonidineTablet0.025 mgOralJamp Pharma Corporation2023-03-07Not applicableCanada flag
Mar-clonidineTablet0.025 mgOralMarcan Pharmaceuticals Inc2022-04-11Not applicableCanada flag
Mint-clonidineTablet0.1 mgOralMint Pharmaceuticals Inc2017-06-23Not applicableCanada flag
Mint-clonidineTablet0.025 mgOralMint Pharmaceuticals Inc2023-05-10Not applicableCanada flag
Mint-clonidineTablet0.2 mgOralMint Pharmaceuticals Inc2017-06-23Not applicableCanada flag
Ntp-clonidineTablet0.025 mgOralTEVA Canada LimitedNot applicableNot applicableCanada flag
Ntp-clonidineTablet0.2 mgOralTEVA Canada LimitedNot applicableNot applicableCanada flag
Ntp-clonidineTablet0.1 mgOralTEVA Canada LimitedNot applicableNot applicableCanada flag
Nu-clonidine Tab 0.1mgTablet.1 mgOralNu Pharm Inc1992-12-312012-09-04Canada flag
Nu-clonidine Tab 0.2mgTablet.2 mgOralNu Pharm Inc1992-12-312012-09-04Canada flag
Sandoz ClonidineTablet0.2 mgOralSandoz Canada Incorporated2022-02-02Not applicableCanada flag
Sandoz ClonidineTablet0.1 mgOralSandoz Canada Incorporated2022-02-02Not applicableCanada flag
Sandoz ClonidineTablet0.025 mgOralSandoz Canada Incorporated2022-02-02Not applicableCanada flag
Teva-clonidineTablet0.025 mgOralTEVA Canada Limited2008-06-26Not applicableCanada flag
Teva-clonidineTablet0.1 mgOralTEVA Canada Limited1993-12-31Not applicableCanada flag
Teva-clonidineTablet0.2 mgOralTEVA Canada Limited1993-12-31Not applicableCanada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ClorpresClonidine hydrochloride (0.2 mg/1) + Chlorthalidone (15 mg/1)TabletOralMylan Pharmaceuticals1998-03-132018-02-28US flag
ClorpresClonidine hydrochloride (0.2 mg/1) + Chlorthalidone (15 mg/1)TabletOralMylan Bertek Pharmaceuticals2015-11-012015-11-19US flag
ClorpresClonidine hydrochloride (0.1 mg/1) + Chlorthalidone (15 mg/1)TabletOralMylan Pharmaceuticals1998-03-132018-02-28US flag
ClorpresClonidine hydrochloride (0.1 mg/1) + Chlorthalidone (15 mg/1)TabletOralMylan Bertek Pharmaceuticals2015-11-012015-11-19US flag
ClorpresClonidine hydrochloride (0.2 mg/1) + Chlorthalidone (15 mg/1)TabletOralPhysicians Total Care, Inc.2005-04-152011-06-30US flag
ClorpresClonidine hydrochloride (0.3 mg/1) + Chlorthalidone (15 mg/1)TabletOralMylan Pharmaceuticals1998-03-132018-02-28US flag
ClorpresClonidine hydrochloride (0.3 mg/1) + Chlorthalidone (15 mg/1)TabletOralMylan Bertek Pharmaceuticals2015-11-012015-11-19US flag
ClorpresClonidine hydrochloride (0.1 mg/1) + Chlorthalidone (15 mg/1)TabletOralPhysicians Total Care, Inc.2005-01-262011-06-30US flag
Combipres 0.1/15 TabClonidine hydrochloride (.1 mg) + Chlorthalidone (15 mg)TabletOralBoehringer Ingelheim (Canada) Ltd Ltee1974-12-311997-08-14Canada flag
KapvayClonidine hydrochloride (0.1 mg/1) + Clonidine hydrochloride (0.2 mg/1)KitOralShionogi2010-12-092014-08-31US flag
KapvayClonidine hydrochloride (0.1 mg/1) + Clonidine hydrochloride (0.2 mg/1)KitOralShionogi2010-12-092014-08-31US flag

Categories

ATC Codes
S01EA04 — ClonidineC02LC01 — Clonidine and diureticsC02AC01 — ClonidineN02CX02 — ClonidineC02LC51 — Clonidine and diuretics, combinations with other drugs
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as dichlorobenzenes. These are compounds containing a benzene with exactly two chlorine atoms attached to it.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Halobenzenes
Direct Parent
Dichlorobenzenes
Alternative Parents
Aniline and substituted anilines / Aryl chlorides / Imidazolines / Guanidines / Propargyl-type 1,3-dipolar organic compounds / Carboximidamides / Azacyclic compounds / Organopnictogen compounds / Organochlorides / Hydrocarbon derivatives
Substituents
1,3-dichlorobenzene / 2-imidazoline / Aniline or substituted anilines / Aromatic heteromonocyclic compound / Aryl chloride / Aryl halide / Azacycle / Carboximidamide / Guanidine / Hydrocarbon derivative
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
clonidine (CHEBI:3757)
Affected organisms
  • Humans and other mammals

Chemical Identifiers

UNII
MN3L5RMN02
CAS number
4205-90-7
InChI Key
GJSURZIOUXUGAL-UHFFFAOYSA-N
InChI
InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)
IUPAC Name
N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine
SMILES
ClC1=CC=CC(Cl)=C1NC1=NCCN1

References

Synthesis Reference

David R. Pierce, William D. Dean, Michael E. Deason, "Process for preparation of clonidine derivatives." U.S. Patent US5684156, issued October, 1968.

US5684156
General References
  1. Hossmann V, Maling TJ, Hamilton CA, Reid JL, Dollery CT: Sedative and cardiovascular effects of clonidine and nitrazepam. Clin Pharmacol Ther. 1980 Aug;28(2):167-76. [Article]
  2. Khan ZP, Ferguson CN, Jones RM: alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999 Feb;54(2):146-65. doi: 10.1046/j.1365-2044.1999.00659.x. [Article]
  3. Sjoberg RJ, Simcic KJ, Kidd GS: The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. Arch Intern Med. 1992 Jun;152(6):1193-7. [Article]
  4. Sliwinska-Mosson M, Zielen I, Milnerowicz H: New trends in the treatment of nicotine addiction. Acta Pol Pharm. 2014 Jul-Aug;71(4):525-30. [Article]
  5. Fresquez-Chavez KR, Fogger S: Reduction of opiate withdrawal symptoms with use of clonidine in a county jail. J Correct Health Care. 2015 Jan;21(1):27-34. doi: 10.1177/1078345814557630. Epub 2014 Nov 26. [Article]
  6. Vasseur B, Dufour A, Houdas L, Goodwin H, Harries K, Emul NY, Hutchings S: Comparison of the Systemic and Local Pharmacokinetics of Clonidine Mucoadhesive Buccal Tablets with Reference Clonidine Oral Tablets in Healthy Volunteers: An Open-Label Randomised Cross-Over Trial. Adv Ther. 2017 Aug;34(8):2022-2032. doi: 10.1007/s12325-017-0585-9. Epub 2017 Jul 19. [Article]
  7. Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF: CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos. 2010 Sep;38(9):1393-6. doi: 10.1124/dmd.110.033878. Epub 2010 Jun 22. [Article]
  8. FDA Approved Drug Products: Catapres Clonidine Hydrochloride Oral Tablets [Link]
  9. FDA Approved Drug Products: Catapres Clonidine Transdermal System [Link]
  10. FDA Approved Drug Products: Duraclon Clonidine Hydrochloride Injection Solution [Link]
  11. FDA Approved Drug Products: Kapvay (clonidine hydrochloride) Oral Extended Release Tablets [Link]
  12. Cayman Chemicals: Clonidine MSDS [Link]
Human Metabolome Database
HMDB0014714
KEGG Drug
D00281
PubChem Compound
2803
PubChem Substance
46508119
ChemSpider
2701
BindingDB
14062
RxNav
2599
ChEBI
46632
ChEMBL
CHEMBL134
ZINC
ZINC000000896484
Therapeutic Targets Database
DAP000231
PharmGKB
PA449051
Guide to Pharmacology
GtP Drug Page
PDBe Ligand
CLU
RxList
RxList Drug Page
Drugs.com
Drugs.com Drug Page
PDRhealth
PDRhealth Drug Page
Wikipedia
Clonidine
PDB Entries
2pnc / 7aww
MSDS
Download (73.8 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingTreatmentInguinal Hernias / Spinal Anesthesia therapy1
4CompletedBasic ScienceHeart Failure1
4CompletedPreventionCardiovascular Disease (CVD)1
4CompletedPreventionDiabetic Nephropathy1
4CompletedPreventionHypertension1
4CompletedPreventionPsychomotor Agitation1
4CompletedPreventionShivering1
4CompletedPreventionWithdrawal; Therapeutic Substance1
4CompletedSupportive CareFemoracetabular Impingement / Postoperative pain1
4CompletedTreatmentAcetabular Labrum Tear / Femoro-acetabular Impingement (FAI) / Hip Dysplasia1
4CompletedTreatmentAnalgesia / Pain / Systemic Inflammatory Stress Response1
4CompletedTreatmentAnterior Cruciate Ligament Injury1
4CompletedTreatmentArthritis of the Hip / Fractures, Closed / Knee Arthropathy1
4CompletedTreatmentAttention Deficit Hyperactivity Disorder (ADHD)1
4CompletedTreatmentBimalleolar Fractures of the Ankle / Post Operative Analgesia Duration / Saphenous Nerve Block / Sciatic Nerve Block1
4CompletedTreatmentCritically Ill Patients / Deep Sedations / Respiration; Artificial / Sedation, Conscious1
4CompletedTreatmentGilles de la Tourette's Syndrome / Tic Disorders1
4CompletedTreatmentGlycemia During Coronary Artery Bypass Graft / Sedation During Pre-anesthetic Medication1
4CompletedTreatmentHypertension2
4CompletedTreatmentLabour1
4CompletedTreatmentLocal Anaesthesia therapy1
4CompletedTreatmentNeonatal drug withdrawal syndrome1
4CompletedTreatmentNerve Block / Pain / Total Knee Arthroplasty (TKA)1
4CompletedTreatmentOpioid Use Disorder (OUD) / Opioid Withdrawal (Disorder)1
4CompletedTreatmentOpioid Withdrawal (Disorder)1
4CompletedTreatmentPain, Labor1
4CompletedTreatmentPeripheral Arterial Occlusive Disease (PAOD)1
4CompletedTreatmentPhysiology1
4CompletedTreatmentPhysiology, Ocular / Regional Blood Flow1
4CompletedTreatmentPostoperative pain2
4CompletedTreatmentPre-Eclampsia1
4CompletedTreatmentTotal Knee and Total Hip Arthroplasty1
4Not Yet RecruitingTreatmentHypertension1
4RecruitingPreventionBipolar Disorder (BD) / Catatonia / Delirium Postseizure / Major Depressive Disorder (MDD)1
4RecruitingPreventionDecline, Cognitive / Delirium / Senescence1
4RecruitingSupportive CareCalcaneus Deformity of Foot / Capsulitis of MTP Joint / Congenital Hand and Foot Deformity / Congenital knee deformity / Congenital Talipes Calcaneus / Congenital Talipes Equinovarus / Feet Pes Planus (Flatfoot) / Finger deformity / Foot; Deformity, Valgus, Congenital / Hand Deformities, Congenital / Hollow Foot / Leg Length Inequality in Children / Osteomyelitis of Hindfoot / Osteomyelitis of Midfoot / Osteomyelitis of the Foot / Polydactylia / Polydactyly Toe / Polydactyly; Fingers / Polysyndactyly / Subungual Exostosis / Syndactyly / Talipes Equinovarus / Tarsal Coalition / Thumb Aplasia / Thumb Hypoplasia / Toe Deformity / Toe Joint Deformity / Trigger Finger / Valgus Foot Deformity1
4RecruitingTreatmentAcute Pain / Endometriosis / Postoperative pain / Postoperative Pain, Acute1
4RecruitingTreatmentCritically Ill Patients / Delirium1
4RecruitingTreatmentInfant, Premature, Diseases / Procedural Pain / Retinopathy of Prematurity (ROP)1
4RecruitingTreatmentInstability of Lumbar Spine / Intervertebral Disc, Degenerative / Lumbar Spine Disc Herniation / Radiculopathy Lumbar / Spinal Stenosis of Lumbar Region / Spondylolisthesis, Degenerative / Spondylolisthesis, Lumbar Region / Spondylosis Lumbar / Synovial cyst1
4RecruitingTreatmentNeonatal drug withdrawal syndrome1
4RecruitingTreatmentPostoperative pain1
4RecruitingTreatmentSickle Cell Disease (SCD) / Vaso-Occlusive Pain Episode in Sickle Cell Disease1
4TerminatedBasic ScienceAnxiety / Hypertension1
4TerminatedTreatmentBipolar Disorder, Mania1
4TerminatedTreatmentDelirium1
4TerminatedTreatmentNeonatal drug withdrawal syndrome1
4TerminatedTreatmentOsteoarthritis of the Knee1
4Unknown StatusDiagnosticAtaxia-Telangiectasia (A-T) / Growth Failure1
4Unknown StatusPreventionCardiovascular Disease (CVD)1
4Unknown StatusPreventionPostoperative pain1
4Unknown StatusTreatmentAnesthetics Adverse Reaction / Hemodynamics Instability / Nausea / Paralytic Ileus / Postoperative pain / Vomiting1
4Unknown StatusTreatmentAttention Deficit Hyperactivity Disorder (ADHD) / Gilles de la Tourette's Syndrome1
4Unknown StatusTreatmentHypertension1
4Unknown StatusTreatmentNeonates / Spinal Anesthesia therapy1
4Unknown StatusTreatmentPain, Labor1
4Unknown StatusTreatmentPostoperative pain2
4Unknown StatusTreatmentProctological Surgery1
4WithdrawnPreventionKnee Arthroscopy / Shoulder Arthroscopy1
4WithdrawnSupportive CarePain Management / Total Knee Arthroplasty (TKA)1
4WithdrawnTreatmentDegenerative Joint Disease / Osteoarthritis (OA)1
4WithdrawnTreatmentOsteoarthritis of the Knee1
4WithdrawnTreatmentPain, Labor1
4WithdrawnTreatmentSymptomatic Irreversible Pulpitis (SIP)1
3Active Not RecruitingTreatmentNeonatal drug withdrawal syndrome1
3CompletedPreventionCardiovascular Disease (CVD)1
3CompletedPreventionIs an Only Child1
3CompletedPreventionNegative Behaviour Change1
3CompletedPreventionNormal Pregnancies1
3CompletedSupportive CareMalignant Neoplasms of Male Genital Organs1
3CompletedTreatmentAttention Deficit Hyperactivity Disorder (ADHD)4
3CompletedTreatmentBiceps Tendonitis1
3CompletedTreatmentBileacid Malabsorption / Fecal Incontinence1
3CompletedTreatmentCritically Ill Patients1
3CompletedTreatmentCritically Ill Patients / Delirium1
3CompletedTreatmentHyperemesis Gravidarum1
3CompletedTreatmentLocoregional Analgesia in Breast Surgery1
3CompletedTreatmentLumbar epidural anesthesia therapy1
3CompletedTreatmentPain1
3CompletedTreatmentPostoperative pain1
3CompletedTreatmentRadiculopathy, Lumbosacral Region1
3Not Yet RecruitingSupportive CareAnalgesia / Nausea, Postoperative / Opioids Use / Postoperative pain / Vomiting, Postoperative1
3Not Yet RecruitingTreatmentDelirium1
3RecruitingTreatmentPost Traumatic Stress Disorder (PTSD) / Sleep1
3RecruitingTreatmentPreschool Children1
3TerminatedTreatmentPain1
3TerminatedTreatmentRadiculopathy, Lumbosacral Region1
3TerminatedTreatmentScoliosis1
3TerminatedTreatmentSedation in Intensive Care Unit Patients1
3Unknown StatusSupportive CareIntraoperative Neurophysiological Monitoring / Pain Management1
3Unknown StatusTreatmentDiabetic Neuropathies / Pain1
3WithdrawnTreatmentPostoperative Hyperalgesia1
2Active Not RecruitingOtherBreast Cancer1
2Active Not RecruitingSupportive CareBreast Cancer / Hot Flashes1
2CompletedSupportive CareCholesteatoma / Implants, Cochlear / Mastoidectomy / Tympanomastoid Surgery1
2CompletedSupportive CarePostoperative pain1
2CompletedTreatmentAnesthesia therapy2
2CompletedTreatmentAttention Deficit Hyperactivity Disorder (ADHD)1
2CompletedTreatmentBack pain / Back Pain Lower Back / Neck Pain1
2CompletedTreatmentBrain Injury / Craniocerebral Injuries / Trauma, Nervous System / Traumatic Brain Injury (TBI)1
2CompletedTreatmentChronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)1
2CompletedTreatmentDiabetes / Painful Diabetic Neuropathy (PDN)1
2CompletedTreatmentDiabetic Neuropathies / Neuropathy / Painful Diabetic Neuropathy (PDN)2
2CompletedTreatmentFascicular Block / Latency Period / Motor Activities / Postoperative pain1
2CompletedTreatmentFecal Incontinence1
2CompletedTreatmentHealthy Volunteers (HV)1
2CompletedTreatmentHerniorrhaphies / Nerve Block / Regional Anesthesia therapy1
2CompletedTreatmentHydrocele / Inguinal Hernias1
2CompletedTreatmentHypersalivation1
2CompletedTreatmentHypertension1
2CompletedTreatmentIndication for Surgery of the Posterior Segment Under Locoregional Anaesthesia1
2CompletedTreatmentMpulse Control Disorders / Parkinson's Disease (PD)1
2CompletedTreatmentNeonatal drug withdrawal syndrome2
2CompletedTreatmentOpioid Related Disorders / Substance Related Disorders1
2CompletedTreatmentOral Mucositis1
2CompletedTreatmentPain2
2CompletedTreatmentPainful Diabetic Neuropathy (PDN)1
2CompletedTreatmentPain / Postoperative1
2CompletedTreatmentPregnancy Related1
2RecruitingPreventionPost Spinal Anesthesia Shivering1
2RecruitingTreatmentMusculoskeletal Disorders / Soft Tissue Masses1
2RecruitingTreatmentPost Traumatic Stress Disorder (PTSD)1
2TerminatedTreatmentDelirium1
2TerminatedTreatmentHypertension / Obesity / Prehypertension1
2TerminatedTreatmentVasospasm1
2Unknown StatusTreatmentAnxiety1
2Unknown StatusTreatmentArrhythmia / Pain1
2WithdrawnTreatmentAutism Disorder1
2WithdrawnTreatmentOther Reconstructive Surgery1
2, 3CompletedPreventionTransversus Abdominis Plane (TAP) Block1
2, 3CompletedTreatmentPre- and Postoperative Analgesia / Renal Cell Carcinoma (RCC) / Spinal Anesthesia therapy1
2, 3CompletedTreatmentSubstance Dependence1
2, 3RecruitingPreventionEmergence Delirium1
2, 3TerminatedDiagnosticSeptic Shock1
2, 3TerminatedSupportive CareChemoradiotherapy-Induced Severe Oral Mucositis1
2, 3TerminatedTreatmentCannabis Dependence / Marijuana Dependence1
2, 3TerminatedTreatmentNeonatal drug withdrawal syndrome1
1CompletedBasic ScienceAmphetamine-Related Disorders / Moods Disorders / Substance Related Disorders1
1CompletedBasic ScienceHealthy (Controls)1
1CompletedScreeningDisorders of the Autonomic Nervous System / Dopamine Beta Hydroxylase Deficiency / Orthostatic Hypotension / Orthostatic Intolerance1
1CompletedTreatmentCocaine Abuse / Heroin Abuse1
1CompletedTreatmentColon Cancer / Postoperative pain1
1CompletedTreatmentCutaneous Nerves CNS Itch1
1CompletedTreatmentHealthy Volunteers (HV)2
1CompletedTreatmentHypertension1
1CompletedTreatmentMechanical Ventilation Complication1
1CompletedTreatmentOpioid Related Disorders1
1Not Yet RecruitingOtherPostoperative pain1
1RecruitingOtherBlood Pressures / Diabetes / Diuretics Drug Reactions / Obesity / Resistance, Insulin / Sympathetic Nerve Activity1
1RecruitingPreventionBloodloss1
1RecruitingTreatmentHIE - Hypoxic - Ischemic Encephalopathy1
1, 2Active Not RecruitingTreatmentChronic Orthostatic Intolerance / Tachycardia1
1, 2CompletedPreventionPostoperative pain1
1, 2CompletedTreatmentAcute Pain / Respiration stimulated / Sedation1
1, 2CompletedTreatmentHIE - Hypoxic - Ischemic Encephalopathy1
1, 2CompletedTreatmentOpioid Addiction / Opioid Dependence / Opioid Related Disorders1
1, 2CompletedTreatmentPostoperative pain1
1, 2TerminatedTreatmentPain1
1, 2WithdrawnTreatmentHypertension / Pregnancy Toxemias / Proteinuria1
1, 2WithdrawnTreatmentTreatment Related Cancer1
0Active Not RecruitingDiagnosticTraumatic Brain Injury (TBI)1
0Active Not RecruitingTreatmentTibial Plateau Fractures1
0CompletedTreatmentCircumcision, Male1
0RecruitingTreatmentStiffness, Aortic / Systolic Hypertension1
0TerminatedBasic ScienceCancer / Neurodegenerative Disorders1
0Unknown StatusTreatmentBlood Pressures / Hypertension1
0WithdrawnBasic ScienceHealthy Volunteers (HV)1
Not AvailableActive Not RecruitingSupportive CarePain Management1
Not AvailableCompletedNot AvailableAnalgesia / Hypnotics and Sedatives / Intensive Care, Neonatal1
Not AvailableCompletedNot AvailableAsphyxia Neonatorum1
Not AvailableCompletedNot AvailableChronic Fatigue Syndrome/ Myalgic Encephalitis (CFS/ME)1
Not AvailableCompletedNot AvailableChronic Pain / Insomnia Chronic2
Not AvailableCompletedNot AvailableCoronavirus Disease 2019 (COVID‑19) / COVID / Hypertension1
Not AvailableCompletedNot AvailableOsteoarthritis of the Knee1
Not AvailableCompletedNot AvailablePain, Labor1
Not AvailableCompletedNot AvailableRhytidoplasty1
Not AvailableCompletedNot AvailableSedation1
Not AvailableCompletedNot AvailableUpper Extremity Surgery1
Not AvailableCompletedBasic ScienceIntrusive Memories1
Not AvailableCompletedBasic ScienceStress (Psychology)1
Not AvailableCompletedPreventionEmergence Delirium1
Not AvailableCompletedPreventionPostoperative pain1
Not AvailableCompletedPreventionSecondary Hyperalgesia1
Not AvailableCompletedSupportive CareAnxiety / Pain1
Not AvailableCompletedSupportive CareOsteoarthritis (OA) / Post-traumatic; Arthrosis1
Not AvailableCompletedTreatmentAscitic Cirrhosis / Hyperactivation of Sympathetic Nervous System1
Not AvailableCompletedTreatmentCerebral Hemorrhage / Intracranial Hemorrhages / Stroke1
Not AvailableCompletedTreatmentOpiate Addiction1
Not AvailableCompletedTreatmentOsteoarthritis of the Knee1
Not AvailableCompletedTreatmentPregnancy1
Not AvailableCompletedTreatmentSchizophrenia1
Not AvailableCompletedTreatmentSubstance Withdrawal Syndrome1
Not AvailableCompletedTreatmentTreatment Resistant Depressive Disorder1
Not AvailableNot Yet RecruitingPreventionPostoperative pain1
Not AvailableNot Yet RecruitingTreatmentUpper Limb Injury1
Not AvailableRecruitingNot AvailableHot Flashes1
Not AvailableRecruitingNot AvailableWithdrawal syndrome1
Not AvailableRecruitingOtherSurgery1
Not AvailableRecruitingTreatmentAnalgesia1
Not AvailableRecruitingTreatmentOsteoarthritis of the Knee or Hip1
Not AvailableRecruitingTreatmentSinus Pilonidal1
Not AvailableTerminatedBasic ScienceComplex Regional Pain Syndrome (RSD)1
Not AvailableTerminatedTreatmentAnxiety / Pain1
Not AvailableTerminatedTreatmentBack pain1
Not AvailableTerminatedTreatmentLumbar and Other Intervertebral Disc Disorders With Radiculopathy1
Not AvailableTerminatedTreatmentNeonatal drug withdrawal syndrome1
Not AvailableTerminatedTreatmentPostoperative pain1
Not AvailableUnknown StatusTreatmentRenal Dialysis1
Not AvailableWithdrawnBasic ScienceExperimental Pain Perception1
Not AvailableWithdrawnTreatmentFull Term Pregnant Patients / Undergoing Lower Segment Caesarian Section1
Not AvailableWithdrawnTreatmentHypertension1
Not AvailableWithdrawnTreatmentVentricular Tachycardia (VT)1

Pharmacoeconomics

Manufacturers
  • Boehringer ingelheim
  • Aveva drug delivery systems inc
  • Mylan technologies inc
  • Tris pharma inc
  • Pharmaforce inc
  • Bioniche pharma usa llc
  • Actavis elizabeth llc
  • American therapeutics inc
  • Dava pharmaceuticals inc
  • Duramed pharmaceuticals inc sub barr laboratories inc
  • Impax laboratories inc
  • Interpharm inc
  • Mutual pharmaceutical co inc
  • Mylan pharmaceuticals inc
  • Par pharmaceutical inc
  • Sandoz inc
  • Teva pharmaceuticals usa inc
  • Unichem laboratories ltd
  • Vintage pharmaceuticals llc
  • Warner chilcott div warner lambert co
  • Watson laboratories inc
  • Shionogi pharma inc
Packagers
  • AAIPharma Inc.
  • Actavis Group
  • Advanced Pharmaceutical Services Inc.
  • Alza Corp.
  • American Regent
  • Amerisource Health Services Corp.
  • Apotheca Inc.
  • APP Pharmaceuticals
  • A-S Medication Solutions LLC
  • Bioniche Pharma
  • Blenheim Pharmacal
  • Boehringer Ingelheim Ltd.
  • Bryant Ranch Prepack
  • Cardinal Health
  • Central Texas Community Health Centers
  • Comprehensive Consultant Services Inc.
  • Coupler Enterprises Inc.
  • DAVA Pharmaceuticals
  • Dept Health Central Pharmacy
  • Direct Dispensing Inc.
  • Dispensing Solutions
  • Diversified Healthcare Services Inc.
  • Global Pharmaceuticals
  • Heartland Repack Services LLC
  • Innoviant Pharmacy Inc.
  • Lake Erie Medical and Surgical Supply
  • Liberty Pharmaceuticals
  • Major Pharmaceuticals
  • Mckesson Corp.
  • Medisca Inc.
  • Murfreesboro Pharmaceutical Nursing Supply
  • Mutual Pharmaceutical Co.
  • Mylan
  • Neighborcare Repackaging Inc.
  • Neuman Distributors Inc.
  • Nucare Pharmaceuticals Inc.
  • Palmetto Pharmaceuticals Inc.
  • Par Pharmaceuticals
  • PCA LLC
  • PD-Rx Pharmaceuticals Inc.
  • Pharmaceutical Utilization Management Program VA Inc.
  • Pharmaforce Inc.
  • Pharmedix
  • Physicians Total Care Inc.
  • Preferred Pharmaceuticals Inc.
  • Prepackage Specialists
  • Prepak Systems Inc.
  • Qualitest
  • Rebel Distributors Corp.
  • Redpharm Drug
  • Remedy Repack
  • Richmond Pharmacy
  • Sandhills Packaging Inc.
  • Southwood Pharmaceuticals
  • Stat Rx Usa
  • Tya Pharmaceuticals
  • UDL Laboratories
  • Unichem Laboratories Ltd.
  • United Research Laboratories Inc.
  • Vangard Labs Inc.
  • Vintage Pharmaceuticals Inc.
  • West-Ward Pharmaceuticals
  • Xanodyne Pharmaceuticals Inc.
Dosage Forms
FormRouteStrength
Injection
Patch, extended releaseTransdermal0.1 mg/24h
Patch, extended releaseTransdermal0.2 mg/24h
Patch, extended releaseTransdermal0.3 mg/24h
TabletOral.300 mg/1
TabletOral0.075 MG
Capsule0.25 MG
Injection, solution150 MICROGRAMMI/ML
TabletOral150 MICROGRAMMI
TabletOral300 MICROGRAMMI
Injection, solutionParenteral0.15 mg/ml
TabletOral0.15 mg/1
TabletOral0.075 mg/1
PatchTransdermal2.5 mg
PatchTransdermal5 mg
PatchTransdermal7.5 mg
TabletOral300 UG
Capsule, extended releaseOral0.25 mg/1
Injection, solution
TabletOral150 mcg
TabletOral15000000 mcg
PatchTransdermal0.1 mg/1d
PatchTransdermal0.2 mg/1d
PatchTransdermal0.3 mg/1d
TabletOral.2 mg
TabletOral
Injection, solutionEpidural0.5 mg/1mL
Injection, solutionEpidural100 ug/1mL
Injection, solutionEpidural500 ug/1mL
Injection, solutionIntravenous100 ug/1mL
Injection, solutionIntravenous500 ug/1mL
TabletOral.1 mg/1
TabletOral.2 mg/1
TabletOral.3 mg/1
TabletOral0.1 mg/1
TabletOral0.100 mg/1
TabletOral0.2 mg/1
TabletOral0.200 mg/1
TabletOral0.3 mg/1
TabletOral0.300 mg/1
Tablet, extended releaseOral25 mg/1
Capsule, extended releaseOral0.25 MG
TabletOral0.3 MG
TabletOral
Injection, solutionEpidural0.1 mg/1mL
Injection, solutionIntravenous0.1 mg/1mL
Injection, solutionIntravenous0.5 mg/1mL
SolutionParenteral150.00 mcg
Solution / dropsOphthalmic
KitOral
Tablet, extended releaseOral0.1 mg/1
Tablet, extended releaseOral0.2 mg/1
For suspension, extended releaseOral0.09 mg/1mL
Suspension, extended releaseOral0.09 mg/1mL
Tablet, extended releaseOral0.17 mg/1
Tablet, extended releaseOral0.26 mg/1
TabletOral.1 mg
TabletOral0.025 mg
TabletOral0.1 mg
TabletOral0.2 mg
TabletOral0.15 mg
Prices
Unit descriptionCostUnit
Catapres-TTS-3 4 0.3 mg/24hr Patches Box328.42USD box
CloNIDine HCl 4 0.3 mg/24hr Patches Box279.9USD box
Catapres-TTS-2 4 0.2 mg/24hr Patches Box236.75USD box
CloNIDine HCl 4 0.2 mg/24hr Patches Box201.75USD box
Catapres-TTS-1 4 0.1 mg/24hr Patches Box141.08USD box
CloNIDine HCl 4 0.1 mg/24hr Patches Box119.84USD box
Catapres-tts 3 patch78.95USD patch
Clonidine 0.3 mg/day patch67.28USD patch
Clonidine hcl powder53.09USD g
Clonidine 0.2 mg/day patch48.5USD patch
Duraclon 500 mcg/ml vial47.4USD ml
Catapres-tts 2 patch39.23USD patch
Clonidine 0.1 mg/day patch28.81USD patch
Catapres-tts 1 patch21.18USD patch
Clonidine 5000 mcg/10 ml vial21.0USD ml
Duraclon 0.1 mg/ml vial14.4USD ml
Clonidine 1000 mcg/10 ml vial5.04USD ml
Catapres 0.3 mg tablet2.98USD tablet
Catapres 0.2 mg tablet2.35USD tablet
Catapres 0.1 mg tablet1.57USD tablet
Clonidine hcl 0.3 mg tablet0.5USD tablet
Clonidine hcl 0.2 mg tablet0.35USD tablet
Catapres 0.2 mg Tablet0.35USD tablet
Apo-Clonidine 0.2 mg Tablet0.33USD tablet
Novo-Clonidine 0.2 mg Tablet0.33USD tablet
Nu-Clonidine 0.2 mg Tablet0.33USD tablet
Dixarit 0.025 mg Tablet0.28USD tablet
Clonidine hcl 0.1 mg tablet0.24USD tablet
Catapres 0.1 mg Tablet0.19USD tablet
Apo-Clonidine 0.1 mg Tablet0.18USD tablet
Novo-Clonidine 0.1 mg Tablet0.18USD tablet
Nu-Clonidine 0.1 mg Tablet0.18USD tablet
Apo-Clonidine 0.025 mg Tablet0.16USD tablet
Novo-Clonidine 0.025 mg Tablet0.16USD tablet
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)Region
US5869100No1999-02-092013-10-13US flag
US8623409No2014-01-072031-09-08US flag
US8337890No2012-12-252027-04-17US flag

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)130http://www.chemspider.com/Chemical-Structure.2701.html?rid=816613e6-a54a-46f0-8152-4a93e09e4170
logP1.59HANSCH,C & LEO,AJ (1985)
Caco2 permeability-4.59ADME Research, USCD
pKa8.05 (at 25 °C)KONTTURI,K & MURTOMAKI,L (1992)
Predicted Properties
PropertyValueSource
Water Solubility0.48 mg/mLALOGPS
logP2.55ALOGPS
logP2.49Chemaxon
logS-2.7ALOGPS
pKa (Strongest Basic)8.16Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area36.42 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity59.09 m3·mol-1Chemaxon
Polarizability21.7 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9632
Blood Brain Barrier+0.9402
Caco-2 permeable+0.8866
P-glycoprotein substrateSubstrate0.6305
P-glycoprotein inhibitor INon-inhibitor0.9061
P-glycoprotein inhibitor IINon-inhibitor0.8383
Renal organic cation transporterInhibitor0.745
CYP450 2C9 substrateNon-substrate0.8219
CYP450 2D6 substrateNon-substrate0.6984
CYP450 3A4 substrateNon-substrate0.6353
CYP450 1A2 substrateNon-inhibitor0.8998
CYP450 2C9 inhibitorNon-inhibitor0.7681
CYP450 2D6 inhibitorInhibitor0.8931
CYP450 2C19 inhibitorNon-inhibitor0.8732
CYP450 3A4 inhibitorNon-inhibitor0.8332
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.803
Ames testNon AMES toxic0.9133
CarcinogenicityNon-carcinogens0.9303
BiodegradationNot ready biodegradable0.9949
Rat acute toxicity3.5030 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.7232
hERG inhibition (predictor II)Non-inhibitor0.8905
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-02vi-8910000000-a3e51d12bf5d7c152fa8
Mass Spectrum (Electron Ionization)MSsplash10-003r-5970000000-33c27878b8b7ad9d5d75
LC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSsplash10-03dl-0279000000-5f6a2e746dea4ac42952
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-001i-0090000000-2c051509a637beaafe73
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-001i-0090000000-f1477af875c25c537ccb
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-001i-0090000000-ccdeb1dfce0424b12c0c
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-01po-6950000000-dd68628a46215027ef29
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0006-6900000000-ce531320f1fda74d127e
LC-MS/MS Spectrum - LC-ESI-IT , positiveLC-MS/MSsplash10-03fr-2980000000-24b18e2a89a65b2b178f
MS/MS Spectrum - , positiveLC-MS/MSsplash10-001i-0190000000-7cbbf9fb244993abe922
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-0090000000-c9f28b79d315b0909617
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-004i-0090000000-2d1c9a107773e5467e9c
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-0090000000-de40bcc4aa4e5e4f2f1d
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-004l-2980000000-10e7fb22d63fbe3d13fe
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-01ox-7910000000-57baadf52de240629467
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9800000000-ae51141f009a5c7eabd9
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-141.5208735
predicted
DarkChem Lite v0.1.0
[M-H]-138.30542
predicted
DeepCCS 1.0 (2019)
[M+H]+142.1236735
predicted
DarkChem Lite v0.1.0
[M+H]+141.04381
predicted
DeepCCS 1.0 (2019)
[M+Na]+141.6042735
predicted
DarkChem Lite v0.1.0
[M+Na]+149.7396
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Yes
Actions
Agonist
General Function
Epinephrine binding
Specific Function
Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is clonidine...
Gene Name
ADRA2B
Uniprot ID
P18089
Uniprot Name
Alpha-2B adrenergic receptor
Molecular Weight
49565.8 Da
References
  1. Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A: S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther. 2000 Dec;295(3):1192-205. [Article]
  2. Hein, L. (2004). alpha-Adrenergic system. In Encyclopedic reference of molecular pharmacology (pp. 27-30). Berlin: Springer. [ISBN:9783540298328]
Kind
Protein
Organism
Humans
Pharmacological action
Yes
Actions
Agonist
General Function
Protein homodimerization activity
Specific Function
Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins.
Gene Name
ADRA2C
Uniprot ID
P18825
Uniprot Name
Alpha-2C adrenergic receptor
Molecular Weight
49521.585 Da
References
  1. Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A: S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther. 2000 Dec;295(3):1192-205. [Article]
  2. Hein, L. (2004). alpha-Adrenergic system. In Encyclopedic reference of molecular pharmacology (pp. 27-30). Berlin: Springer. [ISBN:9783540298328]
Kind
Protein
Organism
Humans
Pharmacological action
Yes
Actions
Agonist
General Function
Thioesterase binding
Specific Function
Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazo...
Gene Name
ADRA2A
Uniprot ID
P08913
Uniprot Name
Alpha-2A adrenergic receptor
Molecular Weight
48956.275 Da
References
  1. Fairbanks CA, Stone LS, Kitto KF, Nguyen HO, Posthumus IJ, Wilcox GL: alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther. 2002 Jan;300(1):282-90. [Article]
  2. Lavand'homme PM, Ma W, De Kock M, Eisenach JC: Perineural alpha(2A)-adrenoceptor activation inhibits spinal cord neuroplasticity and tactile allodynia after nerve injury. Anesthesiology. 2002 Oct;97(4):972-80. [Article]
  3. Ozdogan UK, Lahdesmaki J, Hakala K, Scheinin M: The involvement of alpha 2A-adrenoceptors in morphine analgesia, tolerance and withdrawal in mice. Eur J Pharmacol. 2004 Aug 23;497(2):161-71. [Article]
  4. Ozdogan UK, Lahdesmaki J, Mansikka H, Scheinin M: Loss of amitriptyline analgesia in alpha 2A-adrenoceptor deficient mice. Eur J Pharmacol. 2004 Feb 6;485(1-3):193-6. [Article]
  5. Wang XM, Zhang ZJ, Bains R, Mokha SS: Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat. Pain. 2002 Jul;98(1-2):27-35. [Article]
  6. Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A: S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther. 2000 Dec;295(3):1192-205. [Article]
  7. Hein, L. (2004). alpha-Adrenergic system. In Encyclopedic reference of molecular pharmacology (pp. 27-30). Berlin: Springer. [ISBN:9783540298328]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Agonist
General Function
Protein heterodimerization activity
Specific Function
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) prot...
Gene Name
ADRA1A
Uniprot ID
P35348
Uniprot Name
Alpha-1A adrenergic receptor
Molecular Weight
51486.005 Da
References
  1. Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A: S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther. 2000 Dec;295(3):1192-205. [Article]
  2. PDSP Ki Database [Link]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Agonist
General Function
Protein heterodimerization activity
Specific Function
This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) prot...
Gene Name
ADRA1B
Uniprot ID
P35368
Uniprot Name
Alpha-1B adrenergic receptor
Molecular Weight
56835.375 Da
References
  1. Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A: S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther. 2000 Dec;295(3):1192-205. [Article]
  2. PDSP Ki Database [Link]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Agonist
General Function
Alpha1-adrenergic receptor activity
Specific Function
This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.
Gene Name
ADRA1D
Uniprot ID
P25100
Uniprot Name
Alpha-1D adrenergic receptor
Molecular Weight
60462.205 Da
References
  1. Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A: S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther. 2000 Dec;295(3):1192-205. [Article]
  2. PDSP Ki Database [Link]

Enzymes

Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Substrate
Curator comments
Data is limited to an in vitro study.
General Function
Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP1A2
Uniprot ID
P05177
Uniprot Name
Cytochrome P450 1A2
Molecular Weight
58293.76 Da
References
  1. Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF: CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos. 2010 Sep;38(9):1393-6. doi: 10.1124/dmd.110.033878. Epub 2010 Jun 22. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Substrate
General Function
Vitamin d3 25-hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation react...
Gene Name
CYP3A4
Uniprot ID
P08684
Uniprot Name
Cytochrome P450 3A4
Molecular Weight
57342.67 Da
References
  1. Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF: CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos. 2010 Sep;38(9):1393-6. doi: 10.1124/dmd.110.033878. Epub 2010 Jun 22. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Substrate
General Function
Vitamin d 24-hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP1A1
Uniprot ID
P04798
Uniprot Name
Cytochrome P450 1A1
Molecular Weight
58164.815 Da
References
  1. Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF: CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos. 2010 Sep;38(9):1393-6. doi: 10.1124/dmd.110.033878. Epub 2010 Jun 22. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Substrate
General Function
Oxygen binding
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP3A5
Uniprot ID
P20815
Uniprot Name
Cytochrome P450 3A5
Molecular Weight
57108.065 Da
References
  1. Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF: CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos. 2010 Sep;38(9):1393-6. doi: 10.1124/dmd.110.033878. Epub 2010 Jun 22. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Substrate
General Function
Steroid hydroxylase activity
Specific Function
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic...
Gene Name
CYP2D6
Uniprot ID
P10635
Uniprot Name
Cytochrome P450 2D6
Molecular Weight
55768.94 Da
References
  1. Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF: CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos. 2010 Sep;38(9):1393-6. doi: 10.1124/dmd.110.033878. Epub 2010 Jun 22. [Article]

Carriers

Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Binder
General Function
Toxic substance binding
Specific Function
Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloid...
Gene Name
ALB
Uniprot ID
P02768
Uniprot Name
Serum albumin
Molecular Weight
69365.94 Da
References
  1. Khan ZP, Ferguson CN, Jones RM: alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999 Feb;54(2):146-65. doi: 10.1046/j.1365-2044.1999.00659.x. [Article]
  2. FDA Approved Drug Products: Duraclon Clonidine Hydrochloride Injection Solution [Link]

Transporters

Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Toxin transporter activity
Specific Function
Mediates potential-dependent transport of a variety of organic cations. May play a significant role in the disposition of cationic neurotoxins and neurotransmitters in the brain.
Gene Name
SLC22A3
Uniprot ID
O75751
Uniprot Name
Solute carrier family 22 member 3
Molecular Weight
61279.485 Da
References
  1. Wu X, Huang W, Ganapathy ME, Wang H, Kekuda R, Conway SJ, Leibach FH, Ganapathy V: Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am J Physiol Renal Physiol. 2000 Sep;279(3):F449-58. [Article]
  2. Martel F, Grundemann D, Calhau C, Schomig E: Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. Naunyn Schmiedebergs Arch Pharmacol. 2001 Jan;363(1):40-9. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Symporter activity
Specific Function
Sodium-ion dependent, high affinity carnitine transporter. Involved in the active cellular uptake of carnitine. Transports one sodium ion with one molecule of carnitine. Also transports organic cat...
Gene Name
SLC22A5
Uniprot ID
O76082
Uniprot Name
Solute carrier family 22 member 5
Molecular Weight
62751.08 Da
References
  1. Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, Tsuji A: Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther. 1999 Nov;291(2):778-84. [Article]
  2. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V: Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther. 1999 Sep;290(3):1482-92. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Symporter activity
Specific Function
Sodium-ion dependent, low affinity carnitine transporter. Probably transports one sodium ion with one molecule of carnitine. Also transports organic cations such as tetraethylammonium (TEA) without...
Gene Name
SLC22A4
Uniprot ID
Q9H015
Uniprot Name
Solute carrier family 22 member 4
Molecular Weight
62154.48 Da
References
  1. Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, Tsuji A: Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther. 1999 May;289(2):768-73. [Article]

Drug created at June 13, 2005 13:24 / Updated at May 21, 2024 16:36